TSANZ home

Results for "spiro"

Home 5 Search query for: spiro
Results for "spiro"
VOLUME 7.06 – JULY 2022

VOLUME 7.06 – JULY 2022

Research Roundup:

July 2022

Welcome Message

Welcome to another issue of Research Roundup. Best of luck to everyone who applied for the recent Medical Research Future Fund grants. I hope you have all caught up on some sleep by now!

Speaking of grants there is a whole host of opportunities listed in this newsletter and quite a few are closing soon. TSANZ has two travel grants closing at the start of August, one for the inaugural TSANZSRS Education Hub, and one for the TSANZSRS NZ Branch ASM. Speaking of the NZ Branch ASM, their new investigator award closes on the 14th of August. Outside of TSANZ Cure4CF’s Holckner Family CF Impact Grant is offering up to $500,000 for Cystic Fibrosis research and this grant closes on the 5th of August. For those working outside of research ELF has grants of up to €1,000 for not-for-profit organisations, patient groups and healthcare professionals closing very soon, on the 31st of July.

In addition, the TSANZSRS ASM abstract linked awards have just opened! Details for these awards are outlined below. In related and exciting news, the value of both the Ann Woolcock New Investigator Award and Janet Elder International Travel Awards have increased to $5k each. A lot of the abstract linked awards are targeted to early-mid career researchers. If you fit into this category and have been thinking about submitting an abstract to TSANZ, you should absolutely consider extending your application to go for one, or even both of these awards at the same time. It may just be the steppingstone that takes you that little bit further along your career path.

The Limbic, Respirology and Respiratory Research Review have some excellent reads, and if you’re after further educational opportunities there are some interesting webinars across the next week. RACP are running a COVID webinar series in July, there’s one more session you can catch on the 28th; “COVID-19: Where to now?”. Next month on the 3rd of August ACTnet running a seminar on TB genomics.

Finally, if you ever find yourself feeling a little deprived of motivation, I strongly suggest a google search for Admiral McRaven’s 2014 commencement speech. He outlines 10 life lessons from his time as a navy seal…no wait, don’t stop reading yet. Seriously. I now have each of these printed on 10 A4 pieces of paper on the wall in my office. He has been and continues to be a source of inspiration for me, and for those of you who may be looking for that little push to open your next grant application template, this may be the productive procrastination activity for you.

As always, happy researching everyone.

A/Prof Kristin Carson-Chahhoud
Chair, Research Sub-Committee 

Open Awards

Thoracic Society Awards

TSANZ NZ Branch ASM 2022 Travel Grant – closing 1st August 2022

TSANZSRS NZ Branch Meeting 2022 New Investigator Award – Abstract Submissions close 14th August 2022

How to participate

Follow the links above to access each award application and follow the instructions online.

Please email the TSANZ Awards Coordinator (TSANZawards@thoracic.org.au) with any questions, comments or enquires.

TSANZSRS Annual Scientific Meeting 2023

Call for Abstracts

On behalf of the Organising Committees, we warmly invite you to attend the Annual Scientific Meeting of The Australia and New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand. The TSANZSRS 2023 meeting will be held at Te Pae Christchurch Convention Centre from 25th – 28th March 2023 with opportunities to attend pre-conference Postgraduate Courses on Friday 24th March.

TSANZ abstract awards are now open!

For more information regarding the TSANZSRS 2023 ASM and how to apply for the above awards visit https://www.tsanzsrsasm.com/

 

TSANZ Surveys

Help us improve our educational offerings to members and our skill base by completing the below surveys!

TSANZ Methodology Survey

Evidence-based practice skills among members of the TSANZ

The TSANZ is conducting this voluntary survey to identify members who have specific evidence-based practice (EBP) methodology skills to support the production of position statements and clinical practice guidelines by the Society.

We are asking you to fill out a questionnaire, which should take approximately 15 minutes to complete.

The study gives you an opportunity to tell us about:

  • The skills you have to perform specific elements of a systematic review for the development of Society documents
  • Your interest to learn/improve specific skills or share/teach specific skills

Survey link: https://forms.office.com/r/W6SUisW70g

TSANZ Training Needs Analysis Survey

We are asking all members to complete our first-ever Training Needs Analysis Survey regardless of role, profession, or whether you are clinical or not.

This short survey will only take approximately 12 minutes to complete and is a set of multiple-choice questions.

The Thoracic Society is committed to continuing its development of education offerings and strives to improve our learning opportunities and develop education where gaps exist. We will use this data to evaluate all continuous professional development programs and improve our educational offerings.

This training needs analysis survey utilises the Hennessy-Hicks training needs assessment tool (Hennessy D, Hicks C 2011), endorsed by the World Health Organisation. It will provide reliable information about current performance levels and skill areas requiring further development. It is considered best practice for analysing training needs helping to address problems in turning knowledge into action.

The Thoracic Society would like to thank you for taking the time to complete this survey.

Education Hub Logo

Education Hub Travel Grants

The TSANZ and ANZSRS have established a scheme to assist early-career members to attend the TSANZSRS Education Hub. This is to encourage active participation in the Hub and will be awarded to eligible applicants planning to pursue a career in respiratory medicine or related fields.

The travel grant for the 2022 TSANZSRS Education Hub will be to contribute to travel costs to maximum of AU$250*
* based on individual travel requirements with submitted evidence of costs.

Please click here for more information on the travel grant guidelines and eligibility criteria!

Please click here to register for the TSANZSRS Education Hub!

Respirology – Editor’s Choice

Respirology Issue 27.8 August 2022

Inhalational Exposures in Patients with Fibrotic Interstitial Lung Disease: Presentation, Pulmonary Function, and Survival in the Canadian Registry for Pulmonary Fibrosis

Cathryn T. Lee,Mary E. Strek,Ayodeji Adegunsoye,Alyson W. Wong,Deborah Assayag,Gerard Cox,Charlene D. Fell,Jolene H. Fisher,Andrea S. Gershon,Andrew J. Halayko,Nathan Hambly,Nasreen Khalil,Martin Kolb,Stacey D. Lok,Hélène Manganas,Veronica Marcoux,Julie Morisset,Mohsen Sadatsafavi,Shane Shapera,Teresa To,Pearce Wilcox,Christopher J. Ryerson,Kerri A. Johannson

DOI: 10.1111/resp.14267

 

External Grant Opportunities

European Lung Foundation Healthy Lungs for Life Grants

European Lung Foundation (ELF) is offering grants to support Healthy Lungs for Life activities.

Not-for-profit organisations, patient groups and healthcare professionals can apply for a grant of up to €1,000 to support events and activities that meet one or more of the aims of the Healthy Lungs for Life campaign:

Increase knowledge of the impact of poor air quality on lung health and the actions that everyone can take to reduce air pollution and avoid exposure
Highlight the benefits of quitting smoking
Increase knowledge of the importance of physical activity for lung health
Raise awareness of vaccination to prevent lung infections
This year we also strongly welcome applications linked to the topic of climate change and lung health.

Applications are now open for events focused on World Lung Day and awareness days later in 2022. The closing date for applications is 31 July 2022. To find out more and apply please follow this link.

Cure4 Cystic Fibrosis Foundation National Grant Round

Grant Round Now Open – Holckner Family CF Impact Grant

In 2022 Cure4CF will provide up to $500,000 to advance medical innovations in cystic fibrosis. We prioritise research with a clear translational path that seeks to develop therapies or cures that will result in an increase in average life expectancy of people with cystic fibrosis with consideration given to quality of life. Grant round closes August the 5th at 5pm ACST.

Visit https://www.cure4cf.org/research-grants-2022/ to find out more

Merck Investigator Studies Program (MISP): SARS CoV-2/COVID-19 Investigator Initiated Grants

Effective January 2022, the Merck Investigator Studies Program Review Committee (MISP-RC) for SARS CoV-2/COVID-19 TREATMENT will accept FUNDING ONLY, PRECLINICAL, and CLINICAL, NON-INTERVENTIONAL, submissions within our current areas of interest (AOI). This is a competitive review process that will be conducted by the MISP Review Committee. Decisions will be made on the basis of scientific merit and strategic fit within the AOI. Please review the critical activities and abide by the timelines as outlined below. Clinical, interventional/treatment AOIs will be added at an upcoming date; until then any submission for use of molnupiravir in a treatment or prophylaxis study WILL NOT be reviewed. The following areas are of interest to Investigator Studies Program Committee:

  • In vitro studies to assess the antiviral activity of NHC against RNA viruses of human significance
  • Proof of concept studies demonstrating the antiviral activity and mechanism of action of molnupiravir in validated animal models of zoonotic RNA viral infections
  • In vitro or animal studies to assess the development and mechanism of viral resistance to NHC/molnupiravir by RNA viruses of human significance
  • In vitro or animal studies to assess the relationship between the number and type of accumulated errors in the viral genome and impact on viral infectivity
  • Studies that may validate a standardized definition for post-acute SARS-COV2 (PASC) or long-COVID
  • Studies that may provide clinical or biomarker predictors of infection severity in COVID-19 in children (<18 yr olds)
  • Studies that may better characterize moderate/severe breakthrough infections and/or provide predictors of severe COVID-19 in high risk vaccinated populations such as the elderly, transplant recipients (solid organ or allogeneic stem cell transplant) and other immunocompromised/immunosuppressed patient populations, persons with BMI >30, DM, cardiopulmonary disease, and/or BIPOC, LatinX, native peoples.

Please complete the corresponding preclinical or clinical PROTOCOL and BUDGET templates via the Company’s on-line study management system (in US) or your MSD country representative (outside US). The submissions will be collectively reviewed and selected by the MISP Committee.

https://engagezone.msd.com/SARS_Cov-2_COVID-19.php

Review Cycle 3: August 24, 2022

If you would like more information, or are interested in submitting a proposal related to an area of interest please email mandeep.sembi@msd.com

Surveys and Research

Perspectives on Telehealth for the care of patients with Interstitial Lung Disease (ILD)

We are recruiting health professionals who are involved in the care of patients with Interstitial lung disease (ILD) to participate in this research project. Telehealth for ILD provides an opportunity to improve access to healthcare for patients. Its use has rapidly increased during the COVID-19 pandemic, however there is still a high level of dissatisfaction with telehealth amongst both patients with ILD and healthcare professionals. This study will help us to understand the opinions and experiences of patients with ILD, their caregivers and health professionals of using telehealth in the management of ILD, and ways in which the model can be improved.

Participation in the study will involve taking part in one interview, either in person, over the phone or via zoom. If you are interested in participating or would like further information on this study, please contact:
Dr Sheetal Deshpande
Phone: 03 9903 0214
Email: sheetal.deshpande1@monash.edu

SINFONIA Singing for breathing trial

SINFONIA is a multi-site, online singing for breathing trial for people with COPD or ILD and their caregivers. This study is led by a research team at Monash University (A/Prof Natasha Smallwood) and aims to investigate if group singing classes assist with improvement in symptom management and overall wellbeing. The trial is not just limited to people in Victoria, as people from around Australia can be referred or self-refer to take part. In case you are interested in telling your patients about the study, the eligibility criteria are:

  • Patients aged over 18 with a confirmed diagnosis of COPD or ILD on lung function (within last 2 years) or CT (last 5 years)
  • Stable on treatment for at least 4 weeks (i.e. no new or changed cardiorespiratory medications or hospital admissions for COPD or ILD)
  • Breathless: mMRC ≥ 2
  • NOT currently participating in pulmonary rehabilitation
  • Capable and willing to give informed consent
  • Carers aged over 18 years may also participate

Participants in the online singing group will attend a 90-minute online group singing session once a week, for 12 weeks. People randomised to the control group (delayed entry) will be offered to join the singing sessions after 3 months.

Patients or clinicians can refer by contacting our team’s research assistant Catherine Buchan: c.buchan@alfred.org.au.

Views of healthcare professionals on smoking cessation options project

Are you a health professional who provides smoking cessation advice to the people you see?

Researchers at The University of Queensland are seeking health practitioners for research exploring smoking cessation treatment in a changing regulatory environment. Participation involves a 30 minute interview about your experiences and views on smoking cessation options.

This project is led by Dr Kylie Morphett at the UQ School of Public Health and you can find out more and register your interest here: https://tobacco-endgame.centre.uq.edu.au/our-research/views-healthcare-professionals-smoking-cessation-options-project

We need healthcare professionals involved in pulmonary rehabilitation to complete our online survey

Researchers from the University of Newcastle are conducting an online survey study to better understand current pulmonary rehabilitation programme practices for prescribing exercise intensity for people with chronic obstructive pulmonary disease (COPD). We want to know:
1) How exercise intensity is commonly prescribed; and
2) How the availability of different resources influences current practices around prescription of exercise intensity.

You are eligible to complete the online survey if you have knowledge of how the exercise training is prescribed for people with COPD who attend the pulmonary rehabilitation programme where you work. If this is not your area of expertise, you may forward this study information on to a healthcare provider who would be best placed to complete the survey on behalf of your pulmonary rehabilitation programme.

Participation in this study involves completing a one-off online survey. It is estimated that this survey will take 20-30 minutes to complete. You do not need to complete the survey in one session. You can save it and come back to it later. We will not ask you to enter any information that identifies you or the pulmonary rehabilitation programme where you work.
You can find more information about the survey, and complete the survey, by clicking on this link: https://redcap.hmri.org.au/surveys/?s=989TJJH4NETCY7LY

We are also conducting a parallel survey of people with COPD. If you could please help to distribute this to people who are living with COPD and attend, or have attended, your pulmonary rehabilitation programme, that would be much appreciated. The study information and flyer (with the COPD survey link) that can be sent to people with COPD, can be found by clicking this link: COPD survey (https://1drv.ms/u/s!Ar_gKTMrKI41gWHGMFe57HUfd8p_?e=KBKyxg)
Please contact the lead researcher, Dr Hayley Lewthwaite (hayley.lewthwaite@newcastle.edu.au), if you have any questions about
the online surveys.

Climate Change and Health – WA Healthcare Professionals Survey

The University of Western Australia and Department of Health WA are interested in your views on climate change and health. The information gathered through this project will be used to develop public health messaging and resources for both community and health professionals.

All WA healthcare professionals and healthcare workers with direct client or patient care contact are encouraged to participate. The survey is open from 18 July 2022 to 15 August 2022 and can be accessed online at https://consultation.health.wa.gov.au/pahd-sdu/climate-change-and-health/, and will take approximately fifteen minutes to complete.

Queries can be directed to Sarah Joyce at the Western Australia Department of Health, via email at sarah.joyce@health.wa.gov.au, or by phone on (08) 9222 4017.

LFA COVID-19 Survey

Lung Foundation Australia (LFA) are currently running a survey to gain an understanding of how COVID-19 has impacted Australians and what healthcare, information and support may be needed to help people manage ongoing symptoms. If you’ve had COVID-19 or cared for someone who has, LFA would love to hear your experience by completing this 5-10 minute survey. Completing the survey will put you in the running to win a $150 Visa gift card!

Even if you haven’t had COVID-19, you can share your experience on the government response during the pandemic and the impact of the pandemic on your access to healthcare.

Webinars and Seminars

RACP COVID-19

The RACP COVID-19 Expert Reference Group invites you to attend the upcoming July COVID webinar series.

The RACP have hosted a number of COVID-19 webinar series over the past couple of years in order to inform doctors about important COVID-19 matters, discuss key information and share learnings. We have a great line-up of panellists detailed below and are looking forward to some really engaging discussions.

Please register via the link to attend: REGISTRATION LINK

CALL FOR WEBINAR QUESTIONS – 28 JULY

Do you have any burning questions that you would like us to ask at the webinars? Please send them through to COVIDERG@racp.edu.au.

COVID-19: Where to now?

Thursday 28 July, 6pm-7.30pm AEST / 8pm-9.30pm NZST

This webinar will provide attendees with an understanding of some of the lessons learned though the COVID-19 pandemic and how they might be applied moving forward. The webinar will be in the format of an open panel discussion to guided questions as well as Q&A from webinar attendees.

Hosted by:
Dr Susan Graham, rehabilitation physician and Chair of the RACP COVID-19 Expert Reference Group
Associate Professor Asha Bowen, Head, Skin Health Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute and member of the RACP COVID-19 Expert Reference Group

Expert panellists include:
Professor Paul Kelly, Chief Medical Officer, Department of Health
Professor Christopher Blyth, Director, Wesfarmers Centre of Vaccines and Infectious Diseases; Paediatric Infectious Diseases Physician and Clinical Microbiologist
Professor John Massie, Respiratory Physician and Clinical Director, Children’s Bioethics Centre, Royal Children’s Hospital
Dr Paresh Dawda, General Practitioner, Director and Principal Prestantia Health and Next Practice Canberra
Helen Kulas, NSW Respiratory Network Manager
Professor Peter Wark, Senior Staff Specialist – Respiratory and Sleep Medicine, John Hunter Hospital; Co-Chair NSW Respiratory Network

ACTnet TB Genomics Seminar

Whole genome sequencing of Mycobacterium tuberculsosis is increasingly being
implemented for antimicrobial resistance prediction and transmission surveillance. Join us as our expert panellists discuss the application of this technology for TB control.

When: 3rd August 2022
Time: 1200pm-1330pm (AEST)
Register: Here

Speakers

Dr Chris Coulter, QLD MRL – Topic: Introduction TB to Genomics
Dr Chris Coulter is a Microbiologist, the Chair of TB Expert Advisory Group for Tuberculosis in Queensland, and the Director of the Queensland Mycobacterium Reference Laboratory

Dr Norelle Sherry – Topic: Implementation of TB Genomics for Antimicriobial Resistance Prediction and Public Health
Dr Norelle Sherry is an Infectious Diseases Physician & Clinical Microbiologist, co-appointed at MDU-PHL and Austin Health, with a special interest in antimicrobial resistance (AMR). She is also a clinician-researcher, investigating the use of genomics for surveillance of antimicrobial resistance in multiple different settings, and translation of genomics from the research lab into clinical use.

Prof Vitali Sintchenko – Topic: Case Studies in TB Genomics
Professor Vitali Sintchenko is a leading public health microbiologist and informatician who conducts research on biosurveillance of communicable diseases. He is a Fellow of the Royal College of Pathologists of Australasia and the Australian College of Health Informatics. As the Director of CIDM-Public Health (a translational research hub funded by NSW Health), he leads a public health and diagnostic microbiology team working toward improving laboratory and epidemiological. investigations of communicable diseases.

TBPod

The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

tb pod logo

 

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

VOLUME 7.06 – JULY 2022

VOLUME 7.05 – JUNE 2022

Research Roundup:

June 2022

Welcome Message

Welcome to the June issue of TSANZ Research Round up. First up, I’ve got some questions for you to think about. What do you need to make your funding applications more competitive? Is there a gap in your skills, knowledge base, network, or something else, but you just can’t find a way to fill it? Is there some training that you would really like to get, but can’t find a course or person able to provide it? TSANZ wants to fix these problems for you, but we can’t do that unless you tell us what your needs are.

To do this, please fill out the training needs analysis survey, which should take around 12-minutes and can be accessed here. Big thank you to everyone who has already completed this survey. So that we can provide all our members with the best and most tailored support possible, we need to get at least 300 people to complete this survey, but so far, we have about 100. Thank you to everyone who has already done this. It’s very much appreciated. Would you mind asking anyone and everyone around you to also fill this out? If you like, you could even try and skew the data by having everyone you know request the same training needs, to try and get TSANZ to deliver the support you need first. On that note, Graham, John, Anne, and Hannah, no need to re-read that last sentence or look closer into submissions from my network; Nothing to see here.

While we’re on the topic of training, early bird registration is now open for the inaugural TSANZSRS Education Hub. This is an exciting opportunity for a much needed in-person event, running in Sydney from the 14-15th of October. Yes, you read that right, IN PERSON! There will be a host of workshops to choose from, including sessions to help build skills in crafting successful grant applications and how to get your research published in high quality journals. Of course, one of the biggest benefits of an in-person gathering will be facilitated through the Friday night networking event. Providing an opportunity to reconnect in person with distant colleagues and begin to explore new associations among members with shared interests.

In some other exciting news, a big congratulations to all recipients of Lung Foundation Australia’s Hope Research Fund Grants, and to our members who have been successful with NHMRC Clinical Trials and Cohort Studies Grants. It is fantastic to see this essential respiratory research being supported through competitive grants and awards. Speaking of successes, we would love to help celebrate any of your recent achievements with the broader TSANZ membership by sharing the news in future editions of the research roundup. Instructions on how to do this are provided below.

As usual there are some excellent reads from the Research Review, and Respirology has a special issue focused on occupational lung health. Cure4CF’s Holckner Family CF Impact Grant has just opened, with up to $500,000 is available for Cystic Fibrosis research seeking to develop therapies and cures for the disease. Recruitment is being sought for patients with COPD or ILD for SINFONIA, a singing for breathing trial, and views from healthcare professionals within three different studies. If you have a minute to spare, please help support fellow TSANZ members by contributing to their research.

Finally, some inspirational words to end this edition of research round-up come from anonymous “Not all storms come to disrupt your life, some come to clear your path”.

Happy researching everyone.

A/Prof Kristin Carson-Chahhoud
Chair, Research Sub-Committee 

TSANZ Training Needs Analysis Survey

We are asking all members to complete our first-ever Training Needs Analysis Survey regardless of role, profession, or whether you are clinical or not.

This short survey will only take approximately 12 minutes to complete and is a set of multiple-choice questions.

The Thoracic Society is committed to continuing its development of education offerings and strives to improve our learning opportunities and develop education where gaps exist. We will use this data to evaluate all continuous professional development programs and improve our educational offerings.

This training needs analysis survey utilises the Hennessy-Hicks training needs assessment tool (Hennessy D, Hicks C 2011), endorsed by the World Health Organisation. It will provide reliable information about current performance levels and skill areas requiring further development. It is considered best practice for analysing training needs helping to address problems in turning knowledge into action.

The Thoracic Society would like to thank you for taking the time to complete this survey.

Open Awards

Thoracic Society Awards

TSANZ NZ Branch ASM 2022 Travel Grant – closing 1st August 2022

How to participate

Follow the links above to access each award application and follow the instructions online.

Please email the TSANZ Awards Coordinator (TSANZawards@thoracic.org.au) with any questions, comments or enquires.

Education Hub Logo

TSANZ Education Hub

Registrations are now open for the inaugural TSANZSRS Education Hub on 14-15 October 2022, at Rydges World Square, Sydney.

There will be a wide range of workshops, courses and skills sessions available to choose from, including research skills updates, such as how to craft successful research grant and funding applications, and writing research outcomes for publication.

To view the programme, please visit the Education Hub website.

Of course, there will also be an opportunity to reconnect with colleagues from across Australia and New Zealand at the networking function on the evening of Friday 14th October.

All programme content will be recorded and made available to delegates for 6-months after the Education Hub, giving you access to the entire program, regardless of which sessions you attend at the time.

Register before 4th August 2022 and receive the early bird rate.

We look forward to welcoming you to the TSANZSRS Education Hub in October.

 

Open Request for TSANZ Member Achievements

TSANZ would like to invite members to share their achievements. One of TSANZ Strategic Objectives is to raise the profile of the respiratory research workforce in Australia and New Zealand, especially those who are TSANZ members. As part of this we would like to share member success in our monthly Research Roundup.

Examples of achievements we would like to hear about are:

  • Receipt of major grants, such as grants from the Medical Research Future Fund or the National Health and Medical Research Council
  • Receipt of major honours, such as those from the Order of Australia
  • Notable recent journal publication
  • Completion of a PhD

Please send notification of these achievements to TSANZawards@thoracic.org.au, along with a short blurb (2-3 sentences) about your achievement for us to share. If applicable please include documentation of your achievement, and, if you would like, provide a photo of yourself. Please also share with us success of your fellow TSANZ members!

TSANZ Members awarded the Lung Foundation Australia’s Hope Research Fund 2022 Grant

At the recent Hope Research Fund lunch on 2 June, 13 exceptional researchers from around the country will be awarded $876k in grants, in several different research areas, including asthma, bronchiectasis, Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease (ILD), and lung cancer. 

Huge congratulations to our talented TSANZ members, 
Lung Foundation Australia – Ludwig Engel Research Grant: Dr. Hayley Scott
Lung Foundation Australia Andrew Harrison Bronchiectasis Fellowship: Prof. Julie Marchant
Lung Foundation Australia John Farrell COPD Fellowship: Dr. Narelle Cox
Lung Foundation Australia – Boehringer Ingelheim Fellowship in COPD: Dr. Arwel Jones
Lung Foundation Australia – Better Breathing Foundation PhD Scholarship in Chronic Lung Disease (full): Mrs. Jessica Walsh
Lung Foundation Australia -Ivan Cash Research Grant: Dr. Sheetal Deshpande
Lung Foundation Australia – Lizotte Family Research Grant: Dr. Peter Bell
PACT Grant-In-Aid: Dr Hayley Barnes and Dr Ryan Hoy
CREATE Hope Fellowship (scientific): Dr Gang Liu
CREATE Hope Fellowship (clinical): Dr Ingrid Cox
LUCAP PhD Topup: Dr Jess Nash

The Hope Research Fund aims to not only invest in discovering scientific breakthroughs but bring new hope to millions of Australians impacted by lung disease and lung cancer. 

Lung Foundation Australia Launched the Hope Research Fund last year with the vision of creating Australia’s leading national long-term commitment to fund life-changing lung disease and cancer research, which is severely underfunded. 

With a goal of raising $50 million by 2030, the Hope Research Fund relies heavily on the generosity of Gifts in Wills to fund this life changing research. 

TSANZ Members Success with NHMRC Grant Funding

TSANZ wishes to extend our congratulations to the TSANZ Members who were awarded NHMRC Clinical Trials and Cohort Studies Grants. Over $75.3 million in funding was granted to support 33 clinical trials and cohort studies. It was excellent to see some of this go towards respiratory research. 

Professor Gregory Fox, from the University of Sydney was awarded $4.77 million for The FLIRT-TB study: A fluoroquinolone-based regimen to treat the commonest form of drug-resistant tuberculosis. From Professor Fox; “Tuberculosis (TB) is an infectious respiratory disease affecting 10 million people each year worldwide. Resistance to isoniazid, one of the most important first-line antibiotics used to treat TB, leads to increased mortality and more advanced drug resistance. We will undertake the first clinical trial to evaluate the effectiveness of new-generation fluoroquinolones antibiotics in treating isoniazid-resistant TB. This trial will be conducted in Australia, Vietnam and Canada.”

Dr Danielle Wurzel, from the University of Melbourne was awarded $3.72 million for Translatable Evidence To Improve Lung Health Outcomes In First Nations People – A Cohort Study From Birth to 6 Years. From Dr Wurzel; “First Nations children have unacceptably high rates of lung disease which means poorer adult health. Our project, co-designed with Aboriginal researchers, scientists and clinicians, will address the disproportionate burden of lung disease in First Nations People. Through a birth cohort study of First Nations People we will evaluate a range of exposures and biomarkers for lung health indicators to identify high-risk children. This research will inform interventions to prevent early-onset chronic lung diseases and will assist clinicians, researchers and policy makers in our shared vision to Close the Gap. Other TSANZ members who are Chief investigators on this project are Prof Shyamali Dharmage (UoM), Prof Anne Chang (QUT), Prof Paul Robinson (UoS), (QIMR) and Dr Gabrielle McCallum (Menzies).”

Associate Professor Adrian Lowe, from the University of Melbourne was awarded $7.56 million of Testing an implementable strategy to improve infant skin barrier to prevent asthma and preserve lung function: a 4-year follow-up of the existing PEBBLES RCT. From Associate Professor Lowe; “Childhood asthma is a major public health problem worldwide, and poor lung function in childhood increases the risk of chronic adult lung disease and early death. There are currently limited strategies to prevent children developing asthma and early lung function deficits. It has been hypothesised that impaired skin barrier in early life can increase risk of allergic sensitisation and asthma.  In this follow-on study of our large NHMRC funded trial, we will test if an intervention to improve skin barrier can reduce early life asthma and lung function deficits.”

External Grant Opportunities

Cure4 Cystic Fibrosis Foundation National Grant Round

Grant Round Now Open – Holckner Family CF Impact Grant

In 2022 Cure4CF will provide up to $500,000 to advance medical innovations in cystic fibrosis. We prioritise research with a clear translational path that seeks to develop therapies or cures that will result in an increase in average life expectancy of people with cystic fibrosis with consideration given to quality of life. Grant round closes August the 5th at 5pm ACST.

Visit https://www.cure4cf.org/research-grants-2022/ to find out more

Merck Investigator Studies Program (MISP): SARS CoV-2/COVID-19 Investigator Initiated Grants

Effective January 2022, the Merck Investigator Studies Program Review Committee (MISP-RC) for SARS CoV-2/COVID-19 TREATMENT will accept FUNDING ONLY, PRECLINICAL, and CLINICAL, NON-INTERVENTIONAL, submissions within our current areas of interest (AOI). This is a competitive review process that will be conducted by the MISP Review Committee. Decisions will be made on the basis of scientific merit and strategic fit within the AOI. Please review the critical activities and abide by the timelines as outlined below. Clinical, interventional/treatment AOIs will be added at an upcoming date; until then any submission for use of molnupiravir in a treatment or prophylaxis study WILL NOT be reviewed. The following areas are of interest to Investigator Studies Program Committee:

  • In vitro studies to assess the antiviral activity of NHC against RNA viruses of human significance
  • Proof of concept studies demonstrating the antiviral activity and mechanism of action of molnupiravir in validated animal models of zoonotic RNA viral infections
  • In vitro or animal studies to assess the development and mechanism of viral resistance to NHC/molnupiravir by RNA viruses of human significance
  • In vitro or animal studies to assess the relationship between the number and type of accumulated errors in the viral genome and impact on viral infectivity
  • Studies that may validate a standardized definition for post-acute SARS-COV2 (PASC) or long-COVID
  • Studies that may provide clinical or biomarker predictors of infection severity in COVID-19 in children (<18 yr olds)
  • Studies that may better characterize moderate/severe breakthrough infections and/or provide predictors of severe COVID-19 in high risk vaccinated populations such as the elderly, transplant recipients (solid organ or allogeneic stem cell transplant) and other immunocompromised/immunosuppressed patient populations, persons with BMI >30, DM, cardiopulmonary disease, and/or BIPOC, LatinX, native peoples.

Please complete the corresponding preclinical or clinical PROTOCOL and BUDGET templates via the Company’s on-line study management system (in US) or your MSD country representative (outside US). The submissions will be collectively reviewed and selected by the MISP Committee.

https://engagezone.msd.com/SARS_Cov-2_COVID-19.php

Review Cycle 2: May 26, 2022

Review Cycle 3: August 24, 2022

If you would like more information, or are interested in submitting a proposal related to an area of interest please email mandeep.sembi@msd.com

Surveys and Research

SINFONIA Singing for breathing trial

SINFONIA is a multi-site, online singing for breathing trial for people with COPD or ILD and their caregivers. This study is led by a research team at Monash University (A/Prof Natasha Smallwood) and aims to investigate if group singing classes assist with improvement in symptom management and overall wellbeing. The trial is not just limited to people in Victoria, as people from around Australia can be referred or self-refer to take part. In case you are interested in telling your patients about the study, the eligibility criteria are:

  • Patients aged over 18 with a confirmed diagnosis of COPD or ILD on lung function (within last 2 years) or CT (last 5 years)
  • Stable on treatment for at least 4 weeks (i.e. no new or changed cardiorespiratory medications or hospital admissions for COPD or ILD)
  • Breathless: mMRC ≥ 2
  • NOT currently participating in pulmonary rehabilitation
  • Capable and willing to give informed consent
  • Carers aged over 18 years may also participate

Participants in the online singing group will attend a 90-minute online group singing session once a week, for 12 weeks. People randomised to the control group (delayed entry) will be offered to join the singing sessions after 3 months.

Patients or clinicians can refer by contacting our team’s research assistant Catherine Buchan: c.buchan@alfred.org.au.

Physiotherapy and exercise management of patients undergoing thoracic surgery across the continuum

This research project is aiming to describe the current practices of exercise health professionals (e.g., physiotherapy, exercise physiology, allied health assistants) when assessing and managing patients undergoing thoracic surgery for lung cancer across all phases of the treatment continuum (pre-operative to 12 months post-operative).  

You are invited to participate in this project if you are a registered exercise health professional working with people with lung cancer undergoing thoracic surgery across the continuum of care, including pre-operative, post-operative acute, and community/outpatient programs (e.g., pulmonary rehabilitation and/or oncology rehabilitation).  On completion of this survey, you will be given the opportunity to enter the draw to win a new Apple iPad. 

The survey will close on July 22nd.

To complete the survey and to read the Plain Language Statement please visit https://bit.ly/thoracicsurgsurvey.

For further information, please contact A/Professor Catherine Granger Catherine.Granger@unimelb.edu.au or Georgina Whish-Wilson gwhishwilson@student.unimelb.edu.au.

Views of healthcare professionals on smoking cessation options project

Are you a health professional who provides smoking cessation advice to the people you see?

Researchers at The University of Queensland are seeking health practitioners for research exploring smoking cessation treatment in a changing regulatory environment. Participation involves a 30 minute interview about your experiences and views on smoking cessation options.

This project is led by Dr Kylie Morphett at the UQ School of Public Health and you can find out more and register your interest here: https://tobacco-endgame.centre.uq.edu.au/our-research/views-healthcare-professionals-smoking-cessation-options-project

We need healthcare professionals involved in pulmonary rehabilitation to complete our online survey

Researchers from the University of Newcastle are conducting an online survey study to better understand current pulmonary rehabilitation programme practices for prescribing exercise intensity for people with chronic obstructive pulmonary disease (COPD). We want to know:
1) How exercise intensity is commonly prescribed; and
2) How the availability of different resources influences current practices around prescription of exercise intensity.

You are eligible to complete the online survey if you have knowledge of how the exercise training is prescribed for people with COPD who attend the pulmonary rehabilitation programme where you work. If this is not your area of expertise, you may forward this study information on to a healthcare provider who would be best placed to complete the survey on behalf of your pulmonary rehabilitation programme.

Participation in this study involves completing a one-off online survey. It is estimated that this survey will take 20-30 minutes to complete. You do not need to complete the survey in one session. You can save it and come back to it later. We will not ask you to enter any information that identifies you or the pulmonary rehabilitation programme where you work.
You can find more information about the survey, and complete the survey, by clicking on this link: https://redcap.hmri.org.au/surveys/?s=989TJJH4NETCY7LY

We are also conducting a parallel survey of people with COPD. If you could please help to distribute this to people who are living with COPD and attend, or have attended, your pulmonary rehabilitation programme, that would be much appreciated. The study information and flyer (with the COPD survey link) that can be sent to people with COPD, can be found by clicking this link: COPD survey (https://1drv.ms/u/s!Ar_gKTMrKI41gWHGMFe57HUfd8p_?e=KBKyxg)
Please contact the lead researcher, Dr Hayley Lewthwaite (hayley.lewthwaite@newcastle.edu.au), if you have any questions about
the online surveys.

TBPod

The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

tb pod logo

 

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

VOLUME 7.06 – JULY 2022

VOLUME 6.05 – JULY 2021

Research Roundup:

May 2021

Welcome Message

Welcome to another edition of our TSANZ Research Roundup. It was fantastic to see so many people tune-in to our first ever virtual conference earlier this month. I would like to offer a huge congratulations to everyone who has continued to champion respiratory research by adapting approaches and pushing through despite the COVID-19 pandemic. The presentations on display were testimony to our society of dedicated and steadfast professionals.

I am honoured to be taking over as Chair of the Research Sub-Committee from Professor Sandy Hodge, who has done a brilliant job of leading our collective interests over the past four years. If there is anything the committee or I can do to help support your research activities, please do not hesitate to get in touch.

We are please to announce that over $300,000 has been awarded for respiratory research excellence in 2021. Huge congratulations to all the award recipients and good luck with your research. Two awards are currently open, being a TSANZ and National Asthma Council Australia Career Development Fellowship and a NZ Branch travel grant closing 31st of May and 8th of August respectively. There is an Asthma Australia Research Grant and Workshop on offer later this month and calls for applicants in the 2021 Australian Museum Eureka Prizes are open until the 28th of May.

Check out The Limbic, Respirology Editor’s Choice and Respiratory Research Review segments for a snapshot of some great respiratory research going on. Finally, if you have an interest in lung cancer care, acute exacerbations of COPD or helping to inform the top 10 research priorities for pulmonary fibrosis, click on the survey links below.

Enjoy the May edition of your Research Roundup.

A/Prof Kristin Carson-Chahhoud
Chair, Research Sub-Committee 

2021 RESPIRATORY RESEARCH EXCELLENCE AWARD WINNERS

$300,000 FOR LUNG DISEASE RESEARCH ANNOUNCED

(Saturday, 1st May 2021): Over $300,000 in lung research investment was announced this weekend at the Respiratory Research Excellence Awards, presented in a virtual format alongside the Australia and New Zealand Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science (TSANZSRS 2021).

This prestigious selection of awards are presented to TSANZ members who are at various stages of their career and doing outstanding work. These awards aim to support individuals through project funding, fellowships and travel grants.

“This funding enables our researchers to learn more and develop their skills, with the overall goal of preventing, curing and alleviating disability from lung disease. Every dollar invested takes us one step closer to reaching that goal,” said TSANZ President Elect Professor John Upham.

“We’re honoured to be able to support some of Australia’s most innovative researchers working on lung disease and lung health. This research will make a difference to the lives of the 1 in 4 Australians with lung disease,” he said.

Thoracic Society of Australia and New Zealand (TSANZ) – the hosts of TSANZSRS – are pleased to announce awards from Cystic Fibrosis Australia, the National Asthma Council Australia, Lung Foundation Australia and the Centre of Research Excellence in Pulmonary Fibrosis.

“The TSANZ is privileged to support a diverse awards program that recognises the best and brightest minds in respiratory health that will shape the lung health of our communities into the future” said TSANZ CEO, Dr Graham Hall.

The research awards are supported by the generosity of private donations, sponsorship and leveraged financing from recipients’ institutions. Thank you to our generous sponsors and organisational partners for enabling our world-class researchers to continue to create respiratory knowledge and build capacity in the respiratory workforce, with the overall goal to prevent, cure and relieve disability from lung disease.

2021 RESPIRATORY RESEARCH EXCELLENCE AWARD WINNERS

TSANZ would like to congratulate the following Award winners.

TSANZ Janet Elder Travel Award – Early  Career – Maggie Lam, Monash University

TSANZ Janet Elder Travel Award – Early Career – Melissa Preissner, Monash University

TSANZ Janet Elder Travel Award – Early Career – Mariana Hoffman Barbosa, Monash University

BI NZ Primary Care Grant – Sarah Mooney, Auckland University of Technology

Past President’s Scholarship Award – Elena Schneider-Futschik, The University of Melbourne

TSANZ Peter Phelan Research Award – Thomas Iosifidis, Curtin University and Telethon Kids Institute

TSANZ/Maurice Blackburn GIA – Keshav Raj Paudel, University of Technology Sydney

TSANZ Robert Pierce GIA for ILH – Peter Wark, University of Newcastle and Hunter Medical Research Institute

Ann Woolcock New Investigator Award – Nicole Sheers, Austin Health, University of Melbourne

CREATE Grant-in-Aid For new collaborative research between CREATE Fellows (CRE-PF and Lung Foundation Australia) – Gang Liu, Ashleigh Philp & Laura Glenn, UTS, UNSW & The University of Sydney

CREATE Grant-in-Aid For new collaborative research between CREATE Fellows (CRE-PF and Lung Foundation Australia) – Laura Glenn, Alan Teoh, Hayley Barnes & John Mackintosh, RPAH, Alfred Health & Prince Charles Hospital

PACT Grant-in-Aid For Investigator Led Pulmonary Fibrosis Clinical Research (Lung Foundation Australia and CRE-PF) – Yet Hong Khor & Christopher Ryerson, Austin Health & University of British Columbia

CREATE Hope PhD Scholarships in Pulmonary Fibrosis (Lung Foundation Australia and CRE-PF) -Joanna Lee, Monash University

CREATE Hope PhD Scholarships in Pulmonary Fibrosis (Lung Foundation Australia and CRE-PF) -Claudia Sim, Monash University

Open Awards

Thoracic Society Awards

TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship – closing 31 May 2021

TSANZ NZ Branch ASM 2021 Travel Grant – closing 8 August 2021

Asthma Australia Research Grant and Workshop

Asthma Australia would like to invite you to a workshop which aims to share ideas and invoke research partnerships around issues relevant to people disproportionately affected by asthma. At the end of the meeting, Asthma Australia will re-announce a $300,000 Strategic Alliance grant for such work.

At Asthma Australia, we are committed to doing things differently in our quest to help people live freely from their disease and hope you are ready to join us. Thanks to the Ray O’Donnell Belgrave Lions Asthma Research Fund, we are seeking to fund research from Victorian-led research collaborations to answer the evidence gaps and develop solutions for people from the three following population segments disproportionately affected by asthma:

  • Aboriginal and Torres Strait Islander People
  • People facing socioeconomic disadvantage
  • People from culturally and linguistically diverse backgrounds.

We will be holding one workshop (up to 90 minutes) for each population segment and want you to attend.

At the workshops you will hear why this research funding is a priority in Australia for people with asthma. We will facilitate a discussion among participants about why these inequities persist and share ideas around potential collaborations and novel approaches that aim to address them. After the workshops, applications will open to apply for the $300,000 Strategic Alliance Grant. 

    Workshop  details

    1. Culturally and linguistically diverse backgrounds

    When: Wednesday 26th May 11-12:30
    Where: Ethnic Community Council Victoria

    1. People facing socioeconomic disadvantage
      Tuesday 25th May 2-3:30pm
    1. Aboriginal and Torres Strait Islander People
      TBC – please register interest

    If you are interested in applying for this grant, please contact Asthma Australia (via research@asthma.org.auwith your name, organisation and the workshop you would like to attend.  

    2021 Australian Museum Eureka Prizes

    Do you know someone making a difference in their field?

    Entries to the 2021 Australian Museum Eureka Prizes are now open!

    This year, there are 16 prizes on offer that cover a broad spectrum of scientific disciplines, which aim to recognise the achievements of scientists, researchers, and science communicators at all career stages.

    There are prizes available for both individuals and teams, and entrants can either enter themselves or be nominated. The Eureka Prizes are open, but not limited to, those who work in research institutes, government departments, media, corporations, and universities. It’s free to enter and there’s a prize pool of $160,000 to be shared between the winners.

    If you know an individual or team doing outstanding work, why not encourage them to enter?

    Entries close 7pm AEST Friday 28 May

    VIEW THE FULL PRIZE PROGRAM

    Respirology – Editor’s Choice

    Respirology Issue 26.4 April 2021

    Central airway collapse is related to obesity independent of asthma phenotype

    Swati A. Bhatawadekar, Ubong Peters, Ryan R. Walsh, Nirav Daphtary, Erick S. Maclean, Vitor Mori, Kevin Hodgdon, C. Matthew Kinsey, David A. Kaminsky, Jason H.T. Bates and Anne E. Dixon

    DOI: 10.1111/resp.14005

    Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis‐associated ILD: A randomized, open‐label trial

    Tomoyuki Fujisawa, Hironao Hozumi, Yosuke Kamiya, Yusuke Kaida, Taisuke Akamatsu, Hideki Kusagaya, Yasuomi Satake, Kazutaka Mori, Masashi Mikamo, Hiroyuki Matsuda, Koshi Yokomura, Naoki Koshimizu, Mikio Toyoshima, Shiro Imokawa, Hideki Yasui, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Yutaro Nakamura, Naoki Inui, and Takafumi Suda

    DOI: 10.1111/resp.13978

    Surveys and Research

    SURVEY OF LUNG CANCER CARE IN AUSTRALIA

    We would be grateful please for less than 5 minutes of your time to complete this survey which is designed to provide a snapshot of the current status of lung cancer care and MDTs around Australia.

    • These data will help inform vital services planning for lung cancer care and will directly inform ongoing discussions with Government about lung cancer care across Australia.
    • We are only asking for one response from each institution, we suggest it is the lead clinician for the lung cancer MDT.
    • Curtin University Human Research Ethics Committee (HREC) has approved this study (HREC number HRE2021-0031).

    Please follow the link to the Australian-wide Survey of Lung Cancer Care, or use the QR code below.

    Thank you for your time.

    Prof Fraser Brims
    Curtin Medical School
    fraser.brims@curtin.edu.au 

    GP PARTICIPATION REQUIRED

    Investigators from Monash University are conducting a RACGP-funded national survey of GPs regarding the management of patients with acute exacerbations of COPD.

    Acute exacerbations of COPD are a leading cause of hospitalisation, with a substantial proportion of cases being potentially preventable. We are seeking GPs to complete a short survey that aims to better understand current practice and unmet needs in order to optimise care for these patients. Due to the current COVID-19 vaccination rollout across Australia, it is very challenging to secure participation. Any assistance to distribute this among your contacts is greatly appreciated.

    All eligible participants who complete the survey will have the chance to win one of two $250 gift vouchers, and anyone who completes an optional follow-up qualitative interview will receive a $250 gift voucher.

    The survey can be accessed by clicking HERE.

    The survey has been approved by the Monash University Human Research Ethics Committee (MUHREC ref. 26571). If you have any queries, please contact Dr Bianca Perera at bianca.perera@monash.edu, Dr. Chris Barton at chris.barton@monash.edu or Dr Christian Osadnik (Principal investigator) at christian.osadnik@monash.edu.

     

    TOP 10 RESEARCH PRIORITIES FOR PULMONARY FIBROSIS

    A recent research study as part of the NHMRC’s Centre of Research Excellence in Pulmonary Fibrosis grant aimed to identify the top 10 research priorities for pulmonary fibrosis (PF) according to people living with pulmonary fibrosis, caregivers, health professionals and researchers.

    This study has now been completed and below is a summary of the findings from this work.

    The top 3 priorities rank by people with PF and caregivers were:

    1. What medications can reverse scarring in the lungs of people with PF?
    2. What medications can improve lung function in people with PF?
    3. What are the causes of PF?

    The top 3 priorities rank by people with healthcare professionals/researchers were:

    1. What medications can reverse scarring in the lungs of people with PF?
    2. How can we prevent PF?
    3. What are the causes of PF?

    The findings from this study have been published in a peer-reviewed journal and will help guide future research directions.

    (click on the link to view the paper– https://doi.org/10.1136/thoraxjnl-2020-215731)

    The Study team extends their thanks and appreciation to all those who participated in the study for their time and valuable contribution to this work.

    Yours sincerely,

    Anne Holland
    Professor of Physiotherapy (Research), Monash University (anne.holland@monash.edu)

    TBPod

    The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

    Can you help TSANZ make a difference?

    Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

    1. Making a donation to our Benevolent Fund

    The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
    CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

    2. Making a donation to support research

    With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
    Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

    3. Establishing a named award

    For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

    4. Leave TSANZ a gift in your will

    If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
    If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

    5. TSANZ New Zealand Branch Incorporated 

    New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
    CLICK HERE to make a donation.

    Thank you for your continued support of TSANZ.

    VOLUME 7.06 – JULY 2022

    VOLUME 6.04 – MAY 2021

    Research Roundup:

    May 2021

    Welcome Message

    Welcome to another edition of our TSANZ Research Roundup. It was fantastic to see so many people tune-in to our first ever virtual conference earlier this month. I would like to offer a huge congratulations to everyone who has continued to champion respiratory research by adapting approaches and pushing through despite the COVID-19 pandemic. The presentations on display were testimony to our society of dedicated and steadfast professionals.

    I am honoured to be taking over as Chair of the Research Sub-Committee from Professor Sandy Hodge, who has done a brilliant job of leading our collective interests over the past four years. If there is anything the committee or I can do to help support your research activities, please do not hesitate to get in touch.

    We are please to announce that over $300,000 has been awarded for respiratory research excellence in 2021. Huge congratulations to all the award recipients and good luck with your research. Two awards are currently open, being a TSANZ and National Asthma Council Australia Career Development Fellowship and a NZ Branch travel grant closing 31st of May and 8th of August respectively. There is an Asthma Australia Research Grant and Workshop on offer later this month and calls for applicants in the 2021 Australian Museum Eureka Prizes are open until the 28th of May.

    Check out The Limbic, Respirology Editor’s Choice and Respiratory Research Review segments for a snapshot of some great respiratory research going on. Finally, if you have an interest in lung cancer care, acute exacerbations of COPD or helping to inform the top 10 research priorities for pulmonary fibrosis, click on the survey links below.

    Enjoy the May edition of your Research Roundup.

    A/Prof Kristin Carson-Chahhoud
    Chair, Research Sub-Committee 

    2021 RESPIRATORY RESEARCH EXCELLENCE AWARD WINNERS

    $300,000 FOR LUNG DISEASE RESEARCH ANNOUNCED

    (Saturday, 1st May 2021): Over $300,000 in lung research investment was announced this weekend at the Respiratory Research Excellence Awards, presented in a virtual format alongside the Australia and New Zealand Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science (TSANZSRS 2021).

    This prestigious selection of awards are presented to TSANZ members who are at various stages of their career and doing outstanding work. These awards aim to support individuals through project funding, fellowships and travel grants.

    “This funding enables our researchers to learn more and develop their skills, with the overall goal of preventing, curing and alleviating disability from lung disease. Every dollar invested takes us one step closer to reaching that goal,” said TSANZ President Elect Professor John Upham.

    “We’re honoured to be able to support some of Australia’s most innovative researchers working on lung disease and lung health. This research will make a difference to the lives of the 1 in 4 Australians with lung disease,” he said.

    Thoracic Society of Australia and New Zealand (TSANZ) – the hosts of TSANZSRS – are pleased to announce awards from Cystic Fibrosis Australia, the National Asthma Council Australia, Lung Foundation Australia and the Centre of Research Excellence in Pulmonary Fibrosis.

    “The TSANZ is privileged to support a diverse awards program that recognises the best and brightest minds in respiratory health that will shape the lung health of our communities into the future” said TSANZ CEO, Dr Graham Hall.

    The research awards are supported by the generosity of private donations, sponsorship and leveraged financing from recipients’ institutions. Thank you to our generous sponsors and organisational partners for enabling our world-class researchers to continue to create respiratory knowledge and build capacity in the respiratory workforce, with the overall goal to prevent, cure and relieve disability from lung disease.

    2021 RESPIRATORY RESEARCH EXCELLENCE AWARD WINNERS

    TSANZ would like to congratulate the following Award winners.

    TSANZ Janet Elder Travel Award – Early  Career – Maggie Lam, Monash University

    TSANZ Janet Elder Travel Award – Early Career – Melissa Preissner, Monash University

    TSANZ Janet Elder Travel Award – Early Career – Mariana Hoffman Barbosa, Monash University

    BI NZ Primary Care Grant – Sarah Mooney, Auckland University of Technology

    Past President’s Scholarship Award – Elena Schneider-Futschik, The University of Melbourne

    TSANZ Peter Phelan Research Award – Thomas Iosifidis, Curtin University and Telethon Kids Institute

    TSANZ/Maurice Blackburn GIA – Keshav Raj Paudel, University of Technology Sydney

    TSANZ Robert Pierce GIA for ILH – Peter Wark, University of Newcastle and Hunter Medical Research Institute

    Ann Woolcock New Investigator Award – Nicole Sheers, Austin Health, University of Melbourne

    CREATE Grant-in-Aid For new collaborative research between CREATE Fellows (CRE-PF and Lung Foundation Australia) – Gang Liu, Ashleigh Philp & Laura Glenn, UTS, UNSW & The University of Sydney

    CREATE Grant-in-Aid For new collaborative research between CREATE Fellows (CRE-PF and Lung Foundation Australia) – Laura Glenn, Alan Teoh, Hayley Barnes & John Mackintosh, RPAH, Alfred Health & Prince Charles Hospital

    PACT Grant-in-Aid For Investigator Led Pulmonary Fibrosis Clinical Research (Lung Foundation Australia and CRE-PF) – Yet Hong Khor & Christopher Ryerson, Austin Health & University of British Columbia

    CREATE Hope PhD Scholarships in Pulmonary Fibrosis (Lung Foundation Australia and CRE-PF) -Joanna Lee, Monash University

    CREATE Hope PhD Scholarships in Pulmonary Fibrosis (Lung Foundation Australia and CRE-PF) -Claudia Sim, Monash University

    Open Awards

    Thoracic Society Awards

    TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship – closing 31 May 2021

    TSANZ NZ Branch ASM 2021 Travel Grant – closing 8 August 2021

    Asthma Australia Research Grant and Workshop

    Asthma Australia would like to invite you to a workshop which aims to share ideas and invoke research partnerships around issues relevant to people disproportionately affected by asthma. At the end of the meeting, Asthma Australia will re-announce a $300,000 Strategic Alliance grant for such work.

    At Asthma Australia, we are committed to doing things differently in our quest to help people live freely from their disease and hope you are ready to join us. Thanks to the Ray O’Donnell Belgrave Lions Asthma Research Fund, we are seeking to fund research from Victorian-led research collaborations to answer the evidence gaps and develop solutions for people from the three following population segments disproportionately affected by asthma:

    • Aboriginal and Torres Strait Islander People
    • People facing socioeconomic disadvantage
    • People from culturally and linguistically diverse backgrounds.

    We will be holding one workshop (up to 90 minutes) for each population segment and want you to attend.

    At the workshops you will hear why this research funding is a priority in Australia for people with asthma. We will facilitate a discussion among participants about why these inequities persist and share ideas around potential collaborations and novel approaches that aim to address them. After the workshops, applications will open to apply for the $300,000 Strategic Alliance Grant. 

      Workshop  details

      1. Culturally and linguistically diverse backgrounds

      When: Wednesday 26th May 11-12:30
      Where: Ethnic Community Council Victoria

      1. People facing socioeconomic disadvantage
        Tuesday 25th May 2-3:30pm
      1. Aboriginal and Torres Strait Islander People
        TBC – please register interest

      If you are interested in applying for this grant, please contact Asthma Australia (via research@asthma.org.auwith your name, organisation and the workshop you would like to attend.  

      2021 Australian Museum Eureka Prizes

      Do you know someone making a difference in their field?

      Entries to the 2021 Australian Museum Eureka Prizes are now open!

      This year, there are 16 prizes on offer that cover a broad spectrum of scientific disciplines, which aim to recognise the achievements of scientists, researchers, and science communicators at all career stages.

      There are prizes available for both individuals and teams, and entrants can either enter themselves or be nominated. The Eureka Prizes are open, but not limited to, those who work in research institutes, government departments, media, corporations, and universities. It’s free to enter and there’s a prize pool of $160,000 to be shared between the winners.

      If you know an individual or team doing outstanding work, why not encourage them to enter?

      Entries close 7pm AEST Friday 28 May

      VIEW THE FULL PRIZE PROGRAM

      Respirology – Editor’s Choice

      Respirology Issue 26.4 April 2021

      Central airway collapse is related to obesity independent of asthma phenotype

      Swati A. Bhatawadekar, Ubong Peters, Ryan R. Walsh, Nirav Daphtary, Erick S. Maclean, Vitor Mori, Kevin Hodgdon, C. Matthew Kinsey, David A. Kaminsky, Jason H.T. Bates and Anne E. Dixon

      DOI: 10.1111/resp.14005

      Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis‐associated ILD: A randomized, open‐label trial

      Tomoyuki Fujisawa, Hironao Hozumi, Yosuke Kamiya, Yusuke Kaida, Taisuke Akamatsu, Hideki Kusagaya, Yasuomi Satake, Kazutaka Mori, Masashi Mikamo, Hiroyuki Matsuda, Koshi Yokomura, Naoki Koshimizu, Mikio Toyoshima, Shiro Imokawa, Hideki Yasui, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Yutaro Nakamura, Naoki Inui, and Takafumi Suda

      DOI: 10.1111/resp.13978

      Surveys and Research

      SURVEY OF LUNG CANCER CARE IN AUSTRALIA

      We would be grateful please for less than 5 minutes of your time to complete this survey which is designed to provide a snapshot of the current status of lung cancer care and MDTs around Australia.

      • These data will help inform vital services planning for lung cancer care and will directly inform ongoing discussions with Government about lung cancer care across Australia.
      • We are only asking for one response from each institution, we suggest it is the lead clinician for the lung cancer MDT.
      • Curtin University Human Research Ethics Committee (HREC) has approved this study (HREC number HRE2021-0031).

      Please follow the link to the Australian-wide Survey of Lung Cancer Care, or use the QR code below.

      Thank you for your time.

      Prof Fraser Brims
      Curtin Medical School
      fraser.brims@curtin.edu.au 

      GP PARTICIPATION REQUIRED

      Investigators from Monash University are conducting a RACGP-funded national survey of GPs regarding the management of patients with acute exacerbations of COPD.

      Acute exacerbations of COPD are a leading cause of hospitalisation, with a substantial proportion of cases being potentially preventable. We are seeking GPs to complete a short survey that aims to better understand current practice and unmet needs in order to optimise care for these patients. Due to the current COVID-19 vaccination rollout across Australia, it is very challenging to secure participation. Any assistance to distribute this among your contacts is greatly appreciated.

      All eligible participants who complete the survey will have the chance to win one of two $250 gift vouchers, and anyone who completes an optional follow-up qualitative interview will receive a $250 gift voucher.

      The survey can be accessed by clicking HERE.

      The survey has been approved by the Monash University Human Research Ethics Committee (MUHREC ref. 26571). If you have any queries, please contact Dr Bianca Perera at bianca.perera@monash.edu, Dr. Chris Barton at chris.barton@monash.edu or Dr Christian Osadnik (Principal investigator) at christian.osadnik@monash.edu.

       

      TOP 10 RESEARCH PRIORITIES FOR PULMONARY FIBROSIS

      A recent research study as part of the NHMRC’s Centre of Research Excellence in Pulmonary Fibrosis grant aimed to identify the top 10 research priorities for pulmonary fibrosis (PF) according to people living with pulmonary fibrosis, caregivers, health professionals and researchers.

      This study has now been completed and below is a summary of the findings from this work.

      The top 3 priorities rank by people with PF and caregivers were:

      1. What medications can reverse scarring in the lungs of people with PF?
      2. What medications can improve lung function in people with PF?
      3. What are the causes of PF?

      The top 3 priorities rank by people with healthcare professionals/researchers were:

      1. What medications can reverse scarring in the lungs of people with PF?
      2. How can we prevent PF?
      3. What are the causes of PF?

      The findings from this study have been published in a peer-reviewed journal and will help guide future research directions.

      (click on the link to view the paper– https://doi.org/10.1136/thoraxjnl-2020-215731)

      The Study team extends their thanks and appreciation to all those who participated in the study for their time and valuable contribution to this work.

      Yours sincerely,

      Anne Holland
      Professor of Physiotherapy (Research), Monash University (anne.holland@monash.edu)

      TBPod

      The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

      Can you help TSANZ make a difference?

      Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

      1. Making a donation to our Benevolent Fund

      The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
      CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      2. Making a donation to support research

      With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
      Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      3. Establishing a named award

      For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

      4. Leave TSANZ a gift in your will

      If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
      If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

      5. TSANZ New Zealand Branch Incorporated 

      New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
      CLICK HERE to make a donation.

      Thank you for your continued support of TSANZ.

      VOLUME 7.06 – JULY 2022

      VOLUME 6.03 – MARCH 2021

      Research Roundup:

      March 2021

      Welcome Message

      We hope you’ve been keeping safe and well.

      The TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship is now open. This award aims to facilitate the establishment of mid-career invenstigators as independent, self-directed researchers and to foster the development of high-quality respiratory research in Australia and New Zealand.

      Please note that the TSANZ Indigenous Respiratory Nursing Award will be closing 12 April 2021 and the Boehringer Ingelheim New Zealand Primary Care Award will be closing 05 April 2021.

       

      Don’t forget to register for our first ever Virtual Annual Scientific Meeting – TSANZSRS21.

      Finally, please consider helping us to provide essential funding for our world class respiratory researchers and for our TSANZ awards. You can leave a tax deductible donation of your choice in our areas of need, whether it be a donation to our Benevolent Fund or to support research, establishing a named award or leaving TSANZ a gift in your will. Details can be found below.

      Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

      Enjoy the March edition of your Research Roundup.

      Prof Sandra Hodge

      Chair, Research Sub-Committee

      Open Awards

      Thoracic Society Awards

      TSANZ Indigenous Respiratory Nursing Award – extended – closing 12 April 2021

      Boehringer Ingelheim New Zealand Primary Care Award – closing 05 April 2021

      TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship – closing 31 May 2021

        

      How to participate

      Follow the links above to access each award application form and download the information sheet.

      Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

      2021 Australian Museum Eureka Prizes

      Do you know someone making a difference in their field?

      Entries to the 2021 Australian Museum Eureka Prizes are now open!

      This year, there are 16 prizes on offer that cover a broad spectrum of scientific disciplines, which aim to recognise the achievements of scientists, researchers, and science communicators at all career stages.

      There are prizes available for both individuals and teams, and entrants can either enter themselves or be nominated. The Eureka Prizes are open, but not limited to, those who work in research institutes, government departments, media, corporations, and universities. It’s free to enter and there’s a prize pool of $160,000 to be shared between the winners.

      If you know an individual or team doing outstanding work, why not encourage them to enter?

      Entries close 7pm AEST Friday 28 May

      VIEW THE FULL PRIZE PROGRAM

      Registrations open for ASM

      Registrations are now open for our first ever Virtual Annual Scientific Meeting! Be a part of TSANZSRS21 on 1-2 May 2021 from the comfort of your own home.

      Respirology – Editor’s Choice

      Respirology Issue 26.3 March 2021

      The impact of regular bisoprolol on the response to salbutamol in asthma: A double-blind randomized placebo-controlled crossover trial

      Miriam R. Bennett, Catherina L. Chang, Chris Tuffery, Sandra Hopping and Robert J. Hancox

      DOI: 10.1111/resp.13955

      Outcomes of protracted bacterial bronchitis in children: A 5-year prospective cohort study

      Tom J.C. Ruffles, Julie M. Marchant, Ian B. Masters, Stephanie T. Yerkovich, Danielle F. Wurzel, Peter G. Gibson, Greta Busch, Katherine J. Baines, Jodie L. Simpson, Heidi C. Smith-Vaughan, Susan J. Pizzutto, Helen M. Buntain, Gregory Hodge, Sandra Hodge, John W. Upham and Anne B. Chang

      DOI: 10.1111/resp.13950

      ASCOT trial

      ASCOT is a clinical trial that will generate clinical evidence about the most effective treatments and combinations of treatments for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

      The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand, Indian and Denmark. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

      Potential Treatments for COVID-19

      The global response to COVID-19 is working to accelerate diagnostics, vaccines and therapeutics. While remdesivir has been shown to accelerate time to recovery, and low-dose dexamethasone to decrease mortality, more effective therapies are needed.

      ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

      ASCOT Trial Intervention

      ASCOT ADAPT includes 3 treatment domains:

      Domain A (Antiviral)

      1. Standard of care
      2. Standard of care + nafamostat

      Domain B (Antibody)

      1. Standard of care
      2. Standard of care + convalescent plasma

      Domain C (Anticoagulation)

      1. Standard dose thromboprophylaxis
      2. Intermediate dose thromboprophylaxis
      3. Standard dose thromboprophylaxis plus aspirin

      Eligible patients can be randomised to one or more domains concurrently.

      Protocol documents and further details are available at www.ascot-trial.edu.au

       Australasian Society for Medical Research message

      The Thoracic Society is an affiliate member of the ASMR. Please see below for their latest communications.

      Dear ASMR member

      The Australian National Audit Office has informed us that an audit of ‘Health’s Management of the Medical Research Future Fund’ is currently open for contribution. The period for submissions is expected to close on 30 May 2021 and the audit report will be tabled in September 2021.

      “The objective of this audit is to assess whether the Department of Health is effectively managing the Medical Research Future Fund (MRFF)” with respect to the following criteria:

      • “Are the MRFF governance arrangements effective?”
      • “Has MRFF legislation, governance, strategies and priorities guided selection of medical research initiatives?”
      • “Does Health effectively monitor, measure and evaluate MRFF’s performance?”

      Submissions are confidential and can be anonymous (name, address and contact number fields provided are not required for a submission) so I encourage you and your extended networks to contribute instances or evidence around issues relating to the audit criteria for an ASMR submission (please send to president@asmr.org.au), or if you prefer, make a submission directly to the audit webpage.

      While the addition of the MRFF to the health and medical research funding landscape is greatly welcomed, since its inception in 2014, Australian clinicians and researchers have expressed concerns about the MRFF processes and governance. I therefore cannot stress the importance of providing accurate, appropriate and verifiable submissions to the auditors with regard to the audit objective and criteria.

       

      Yours sincerely,
      Dr Ryan Davis
      ASMR President 2021

      Surveys and Research

      SURVEY OF LUNG CANCER CARE IN AUSTRALIA

      We would be grateful please for less than 5 minutes of your time to complete this survey which is designed to provide a snapshot of the current status of lung cancer care and MDTs around Australia.

      • These data will help inform vital services planning for lung cancer care and will directly inform ongoing discussions with Government about lung cancer care across Australia.
      • We are only asking for one response from each institution, we suggest it is the lead clinician for the lung cancer MDT.
      • Curtin University Human Research Ethics Committee (HREC) has approved this study (HREC number HRE2021-0031).

      Please follow the link to the Australian-wide Survey of Lung Cancer Care, or use the QR code below.

      Thank you for your time.

      Prof Fraser Brims
      Curtin Medical School
      fraser.brims@curtin.edu.au 

      TOP 10 RESEARCH PRIORITIES FOR PULMONARY FIBROSIS

      A recent research study as part of the NHMRC’s Centre of Research Excellence in Pulmonary Fibrosis grant aimed to identify the top 10 research priorities for pulmonary fibrosis (PF) according to people living with pulmonary fibrosis, caregivers, health professionals and researchers.

      This study has now been completed and below is a summary of the findings from this work.

      The top 3 priorities rank by people with PF and caregivers were:

      1. What medications can reverse scarring in the lungs of people with PF?
      2. What medications can improve lung function in people with PF?
      3. What are the causes of PF?

      The top 3 priorities rank by people with healthcare professionals/researchers were:

      1. What medications can reverse scarring in the lungs of people with PF?
      2. How can we prevent PF?
      3. What are the causes of PF?

      The findings from this study have been published in a peer-reviewed journal and will help guide future research directions.

      (click on the link to view the paper– https://doi.org/10.1136/thoraxjnl-2020-215731)

      The Study team extends their thanks and appreciation to all those who participated in the study for their time and valuable contribution to this work.

      Yours sincerely,

      Anne Holland
      Professor of Physiotherapy (Research), Monash University (anne.holland@monash.edu)

      TBPod

      The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

      Can you help TSANZ make a difference?

      Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

      1. Making a donation to our Benevolent Fund

      The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
      CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      2. Making a donation to support research

      With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
      Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      3. Establishing a named award

      For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

      4. Leave TSANZ a gift in your will

      If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
      If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

      5. TSANZ New Zealand Branch Incorporated 

      New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
      CLICK HERE to make a donation.

      Thank you for your continued support of TSANZ.

       

      VOLUME 7.06 – JULY 2022

      VOLUME 6.02 – FEBRUARY 2021

      Research Roundup:

      February 2021

      Welcome Message

      We hope you’ve been keeping safe and well.

      We are pleased to announce that the Boehringer Ingelheim New Zealand Primary Care Grant is now open. This grant aims to support research in respiratory health within the primary care sphere in New Zealand. Primary care can include general practice, allied health services, nursing in community health and community pharmacy.

      Please note that a number of awards are closing this Wednesday 24 February. These include our modified travel awards that take into account travel bans and restrictions.

      Don’t forget to register for our first ever Virtual Annual Scientific Meeting – TSANZSRS21.

      Finally, please consider helping us to provide essential funding for our world class respiratory researchers and for our TSANZ awards. You can leave a tax deductible donation of your choice in our areas of need, whether it be a donation to our Benevolent Fund or to support research, establishing a named award or leaving TSANZ a gift in your will. Details can be found below.

      Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

      Enjoy the February edition of your Research Roundup.

      Prof Sandra Hodge
      Chair, Research Sub-Committee

      Open Awards

      Thoracic Society Awards

      TSANZ Indigenous Respiratory Nursing Award – closing 01 April 2021

      Boehringer Ingelheim New Zealand Primary Care Award – closing 05 April 2021

      TSANZ National Asthma Council Australia – Asthma & Airways Fellowship – closing 31 May 2021

      How to participate

      Follow the links above to access each award application form and download the information sheet.

      Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

      Grifols Scientific Awards

      The 18th Annual ALTA Alpha-1-Antitrypsin Laurell’s Training Award is now open.

      Deadline for submission of letter of intent – 1 March 2021

      Deadline for submission of full proposal – 31 May 2021

      Registrations open for ASM

      Registrations are now open for our first ever Virtual Annual Scientific Meeting! Be a part of TSANZSRS21 on 1-2 May 2021 from the comfort of your own home.

      Respirology – Editor’s Choice

      Respirology Issue 26.2 February 2021

      Effects of roflumilast on arterial stiffness in COPD (ELASTIC): A randomized trial

      Matthias H. Urban, Nicole Kreibich, Andreas Gleiss, Georg-Christian Funk, Sylvia Hartl and Otto C. Burghuber

      DOI: 10.1111/resp.13914

       ASCOT trial

      ASCOT is a clinical trial that will generate clinical evidence about the most effective treatments and combinations of treatments for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

      The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand, Indian and Denmark. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

      Potential Treatments for COVID-19

      The global response to COVID-19 is working to accelerate diagnostics, vaccines and therapeutics. While remdesivir has been shown to accelerate time to recovery, and low-dose dexamethasone to decrease mortality, more effective therapies are needed.

      ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

      ASCOT Trial Intervention

      ASCOT ADAPT includes 3 treatment domains:

      Domain A (Antiviral)

      1. Standard of care
      2. Standard of care + nafamostat

      Domain B (Antibody)

      1. Standard of care
      2. Standard of care + convalescent plasma

      Domain C (Anticoagulation)

      1. Standard dose thromboprophylaxis
      2. Intermediate dose thromboprophylaxis
      3. Standard dose thromboprophylaxis plus aspirin

      Eligible patients can be randomised to one or more domains concurrently.

      Protocol documents and further details are available at www.ascot-trial.edu.au

      Surveys and Research

      SURVEY OF LUNG CANCER CARE IN AUSTRALIA

      We would be grateful please for less than 5 minutes of your time to complete this survey which is designed to provide a snapshot of the current status of lung cancer care and MDTs around Australia.

      • These data will help inform vital services planning for lung cancer care and will directly inform ongoing discussions with Government about lung cancer care across Australia.
      • We are only asking for one response from each institution, we suggest it is the lead clinician for the lung cancer MDT.
      • Curtin University Human Research Ethics Committee (HREC) has approved this study (HREC number HRE2021-0031).

      Please follow the link to the Australian-wide Survey of Lung Cancer Care, or use the QR code below.

      Thank you for your time.

      Prof Fraser Brims
      Curtin Medical School
      fraser.brims@curtin.edu.au 

      TOP 10 RESEARCH PRIORITIES FOR PULMONARY FIBROSIS

      A recent research study as part of the NHMRC’s Centre of Research Excellence in Pulmonary Fibrosis grant aimed to identify the top 10 research priorities for pulmonary fibrosis (PF) according to people living with pulmonary fibrosis, caregivers, health professionals and researchers.

      This study has now been completed and below is a summary of the findings from this work.

      The top 3 priorities rank by people with PF and caregivers were:

      1. What medications can reverse scarring in the lungs of people with PF?
      2. What medications can improve lung function in people with PF?
      3. What are the causes of PF?

      The top 3 priorities rank by people with healthcare professionals/researchers were:

      1. What medications can reverse scarring in the lungs of people with PF?
      2. How can we prevent PF?
      3. What are the causes of PF?

      The findings from this study have been published in a peer-reviewed journal and will help guide future research directions.

      (click on the link to view the paper– https://doi.org/10.1136/thoraxjnl-2020-215731)

      The Study team extends their thanks and appreciation to all those who participated in the study for their time and valuable contribution to this work.

      Yours sincerely,

      Anne Holland
      Professor of Physiotherapy (Research), Monash University (anne.holland@monash.edu)

      TBPod

      The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

      Can you help TSANZ make a difference?

      Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

      1. Making a donation to our Benevolent Fund

      The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
      CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      2. Making a donation to support research

      With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
      Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      3. Establishing a named award

      For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

      4. Leave TSANZ a gift in your will

      If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
      If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

      5. TSANZ New Zealand Branch Incorporated 

      New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
      CLICK HERE to make a donation.

      Thank you for your continued support of TSANZ.

      VOLUME 7.06 – JULY 2022

      VOLUME 6.01 – JANUARY 2021

      Research Roundup:

      January 2021

      Welcome Message

      Welcome to the first edition of our TSANZ Research Roundup for 2021. We hope you’ve kept safe and well over the festive season.

      The TSANZ Indigenous Respiratory Nursing Award is now open. This award aims to raise the profile of indigenous health within respiratory nursing and the work of respiratory nurses of an indigenous background.

      The TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health has been extended to 24 February 2021. This award, to honour the memory of the late Prof. Rob Pierce, will be awarded to a member of the TSANZ for a project focused on understanding and improving the lung health of Indigenous people in Australia and/or New Zealand.

      Our two travel awards, TSANZ Janet Elder International Travel Award and Boehringer Ingelheim New Zealand COPD Travel Award have been extended to 24 February 2021. These awards have been modified to allow for professional development or research support instead of travel should the international scientific meetings not proceed or travel restrictions prevent you from attending.

      Don’t forget to take advantage of the earlybird prices for our first ever Virtual Annual Scientific Meeting – TSANZSRS21.

      Finally, please consider helping us to provide essential funding for our world class respiratory researchers and for our TSANZ awards. You can leave a tax deductible donation of your choice in our areas of need, whether it be a donation to our Benevolent Fund or to support research, establishing a named award or leaving TSANZ a gift in your will. Details can be found below.

      Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

      Enjoy the January edition of your Research Roundup.

      Prof Sandra Hodge

      Chair, Research Sub-Committee

       

      Can you help TSANZ make a difference?

      Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

      1. Making a donation to our Benevolent Fund

      The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
      CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      2. Making a donation to support research

      With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
      Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      3. Establishing a named award

      For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

      4. Leave TSANZ a gift in your will

      If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
      If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

      5. TSANZ New Zealand Branch Incorporated 

      New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
      CLICK HERE to make a donation.

      Thank you for your continued support of TSANZ.

       

      Open Awards

      Thoracic Society Awards

      TSANZ Janet Elder International Travel Award – extended – closing 24 February 2021

      Boehringer Ingelheim New Zealand COPD Travel Award – extended – closing 24 February 2021

      TSANZ Peter Phelan Research Grant – closing 27 January 2021

      Maurice Blackburn Occupational Lung Disease Grant-in-Aid – closing 27 January 2021

      TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health – extended – closing 24 February 2021

      TSANZ Indigenous Respiratory Nursing Award – closing 24 February 2021

      Cystic Fibrosis Australia Awards

      Australian Cystic Fibrosis Research Trust 2021 Innovation Grant – closing 29 January 2021

      Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF)

      PACT Grant-in-Aid – closing 14 February 2021

      CREATE Grant-in-Aid – closing 14 February 2021

           

      How to participate

      Follow the links above to access each award application form and download the information sheet.

      Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

       

      Registrations open for ASM

      Registrations are now open for our first ever Virtual Annual Scientific Meeting! Be a part of TSANZSRS21 on 1-2 May 2021 from the comfort of your own home.

      Register now to take advantage of the earlybird prices. Earlybird registrations will be available until 12 February 2021.

       

      Respirology – Editor’s Choice

      Respirology Issue 26.1 January 2021

       

      Disease burden of eosinophilic airway disease: Comparing severe asthma, COPD and asthma–COPD overlap

      Sarah A. Hiles, Peter G. Gibson and Vanessa M. McDonald

      DOI: 10.1111/resp.13841

       

      Effect of short‐course exercise training on the frequency of exacerbations and physical activity in patients with COPD: A randomized controlled trial

      Fanny Wai-San Ko, Wilson Tam, Eddy H.S. Siu, Ka-Pang Chan, Jenny Chun-Li Ngai, So-Shan Ng, Tat On Chan1 and David Shu-Cheong Hui

      DOI: 10.1111/resp.13872

       

       ASCOT trial

      ASCOT is a clinical trial that will generate clinical evidence about the most effective treatments and combinations of treatments for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

      The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand, Indian and Denmark. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

      Potential Treatments for COVID-19

      The global response to COVID-19 is working to accelerate diagnostics, vaccines and therapeutics. While remdesivir has been shown to accelerate time to recovery, and low-dose dexamethasone to decrease mortality, more effective therapies are needed.

      ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

      ASCOT Trial Intervention

      ASCOT ADAPT includes 3 treatment domains:

      Domain A (Antiviral)

      1. Standard of care
      2. Standard of care + nafamostat

      Domain B (Antibody)

      1. Standard of care
      2. Standard of care + convalescent plasma

      Domain C (Anticoagulation)

      1. Standard dose thromboprophylaxis
      2. Intermediate dose thromboprophylaxis
      3. Standard dose thromboprophylaxis plus aspirin

      Eligible patients can be randomised to one or more domains concurrently.

      Protocol documents and further details are available at www.ascot-trial.edu.au

      VOLUME 7.06 – JULY 2022

      VOLUME 5.07 – DECEMBER 2020

      Research Roundup:

      December 2020

      Welcome Message

      Welcome to this month’s edition of our TSANZ Research Roundup.

      This is a busy time for TSANZ and LFA’s research awards, with the Ann Woolcock New Investigator Award and LFA Ludwig Engel Research Award, Lizotte Family Research Award and Ivan Cash Research Awards currently under review. Keep your eyes open for several TSANZ awards opening soon! These will be accessible on the TSANZ Awards Submission Portal and include the new CFA Innovation Grant as detailed below. Also note NHMRC’s Special Initiative in Human Health and Environmental Change (SIHHEC). This will provide a catalytic stimulus to improve Australia’s current capability and capacity in human health and environmental change research, by supporting a single, multidisciplinary, nationally focused, collaborative network of researchers across Australia. The work of this network will help to protect the health of the Australian community and build a resilient and responsive health system. The focus includes improving current understanding of the complex interactions between primary, secondary and tertiary health effects of environmental and climate change.

      Plans for our virtual ASM in 2021 are well underway, with registrations now open. Please visit our TSANZSRS2021 website for more details.

      Finally, please consider helping us to provide essential funding for our world class respiratory researchers and for our TSANZ awards. You can leave a tax deductible donation of your choice in our areas of need, whether it be a donation to our Benevolent Fund or to support research, establishing a named award or leaving TSANZ a gift in your will. Details can be found below.

      Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

      Enjoy the December edition of your Research Roundup.

      Prof Sandra Hodge

      Chair, Research Sub-Committee

      Open Awards

      Thoracic Society Awards

      TSANZ Janet Elder International Travel Award – closing 15 January 2021

      Boehringer Ingelheim New Zealand COPD Travel Award – closing 15 January 2021

      TSANZ Peter Phelan Research Grant – closing 27 January 2021

      TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health – closing 27 January 2021

      Maurice Blackburn Occupational Lung Disease Grant-in-Aid – closing 27 January 2021

      Lung Foundations Awards

      Cochrane Airways Australia Scholarship – closing 4 December 2020

      Cystic Fibrosis Australia Awards

      Australian Cystic Fibrosis Research Trust 2021 Innovation Grant – closing 29 January 2021

      How to participate

      Follow the links above to access each award application form and download the information sheet.

      Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

      Cystic Fibrosis Innovation Grant

      Cystic Fibrosis Australia (CFA) is pleased to announce the 2021 Innovation Grant for post- doctoral researchers, currently working in cystic fibrosis (CF) research. This grant is awarded annually to one applicant for one year.

      The Innovation Grant will allow a CF researcher to explore novel concepts at the initial feasibility stage.  Innovative applications relating to any aspect in the field of CF are encouraged, even those lacking pilot data.  The grant aims to allow the researcher to generate sufficient data within the one-year grant period to be in a position to apply for additional support from an appropriate funding body to continue the research.

      The Innovation grant will be offered to post-doctoral researchers currently working in or proposing to work in CF research.  The researcher will have completed a research higher degree in CF or a related area within the last ten years.

      The recipient of the Innovation Grant is required to provide progress reports on their research to CFA every six months.  In addition, and where appropriate, the recipient will be asked to make a presentation at a CFA conference (held every two years) in Australia.

      The maximum amount awarded under the Innovation Grant will be $80,000.  The actual amount provided will be subject to approval of the applicant’s budget.

      Applications can be made through the website of The Thoracic Society of Australia & New Zealand (TSANZ) and must be received by TSANZ no later than 5.00 pm (AEDT) 29th January 2021.

      Registrations open for ASM

      Registrations are now open for our first ever Virtual Annual Scientific Meeting! Be a part of TSANZSRS21 on 1-2 May 2021 from the comfort of your own home.

      Respirology – Editor’s Choice

      Respirology Issue 25.11 November 2020

       

      Predictive value of control of COPD for risk of exacerbations: An international, prospective study

      Marc Miravitlles, Pawel Sliwinski, Chin Kook Rhee, Richard W. Costello, Victoria Carter, Jessica H.Y. Tan, Therese S. Lapperre, Bernardino Alcazar, Caroline Gouder, Cristina Esquinas, Juan Luis García-Rivero, Anu Kemppinen, Augustine Tee, Miguel Roman-Rodrígues, Juan José Solder-Cataluña, David B. Price and on behlaf of the Respiratory Effectiveness Group (REG)

       

      Cover caption: Control in COPD is a tool to assess clinical patient status and decision making on step-up or down treatment. Uncontrolled status is associated with an increased risk of exacerbations. This is a collaborative international study of REG, a not-for-profit initiative established by international experts in real-life and comparative effectiveness research in respiratory medicine

      DOI: 10.1111/resp.13811

       

      Disease progression across the spectrum of idiopathic pulmonary fibrosis: A multicentre study

      Giacomo Sgalla, Erminia Lo Greco, Mariarosaria Calvello, Francesco Varone, Bruno Iovene, Stefania Cerri, Pierluigi Donatelli, Ada Vancheri, Mauro Pavone, Fabrizio Luppi, Carlo Vancheri and Luca Richeldi

       

      Cover caption: The collaborative research team from three Italian centres in Catania, Rome and Modena. From left to right: Ada Vancheri, Carlo Vancheri, Bruno Iovene, Mauro Pavone, Giacomo Sgalla, Stefania Cerri, Francesco Varone, Luca Richeldi.

      DOI: 10.1111/resp.13805

       

      Respirology Issue 25.12 December 2020

       

       

      Bronchial thermoplasty versus mepolizumab: Comparison of outcomes in a severe asthma clinic

      David Langton, Joy Shia, Suzy Guo, Julie Sharp, Ceri Banks, Wei Wang, Virginia Plumber and Francis Thien

       

      Cover caption:

      Bronchial thermoplasty: Work in progress

      DOI: 10.1111/resp.13830

       

      Cost of hospitalisation for bronchiectasis exacerbation in children

      Vikas Goyal, Steven M McPhail, Frank Hurley, Keith Grimwood, Julie M Marchant, I Brent Masters and Anne B Chang

       

      Cover caption:

      The emblem of AusBREATHE (Australian Bronchiectasis Centre of Research Excellence, especially for Aboriginal and Torres Strait Islander Children) is a reproduction of a painting by First Nations artist and former Menzies employee, who describes how the painting represents the lungs as follows:

      ‘When the earth was made, so were the first trees. They cleaned the air through their branches and leaves. The same is reflected in us with our lungs; they have branches like trees breathing in the air and cleaning our body and provide much needed oxygen.The butterflies represent a delicate balance; if something happens to the air, the butterflies will die. That’s why we must look after our air, like we have to look after our lungs because they keep us alive. The red dots represent alveoli that are at the end of the branches.’

      DOI: 10.1111/resp.13828

      Research Review

      NZ Respiratory Research Review Issue 177

       

      NZ Respiratory Research Review Issue 178

      NZ Respiratory Research Review Issue 179

      As part of an ongoing series focussing on new registrations in Australia, Research Review has released a product review of the use of beclometasone dipropionate/formoterol (Fostair) for patients with asthma.

      This review discusses the evidence in support of the use of Fostair, its pharmacological properties, dosage and administration, and efficacy and tolerability as demonstrated in pivotal clinical trials. It also provides commentary and recommendations from Professor Francis Thien, Director of the Department of Respiratory and Sleep Medicine at Box Hill Hospital, Eastern Health, and the Monash University Clinical School in Melbourne, Australia.

       

      ASCOT trial

      ASCOT is a clinical trial that will generate clinical evidence about treatment for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

      The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand and Asia. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

      Potential Treatments for COVID-19

      There are currently no specific therapies for COVID-19. The two main strategies are to limit the virus replicating (antiviral therapies) or to modulate the immune response (in some severe cases, there is a damaging over exuberant immune response).

      ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

      ASCOT Trial Intervention

      Initially, an open label trial of two existing treatments in a 2×2 factorial design with usual care arm will be conducted.

      1. Lopinavir/ritonavir (kaletra), a combination medicine that is used to treat human immunodeficiency virus-1 (HIV-1) infection
      1. Hydroxychloroquine, a medicine used to treat rheumatoid arthritis and other inflammatory conditions and to prevent and treat malaria.

      Protocol documents and further details are available at www.ascot-trial.edu.au

       

      Can you help TSANZ make a difference?

      Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

      1. Making a donation to our Benevolent Fund

      The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
      CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      2. Making a donation to support research

      With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
      Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      3. Establishing a named award

      For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

      4. Leave TSANZ a gift in your will

      If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
      If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

      5. TSANZ New Zealand Branch Incorporated 

      New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
      CLICK HERE to make a donation.

      Thank you for your continued support of TSANZ.

       

      When Infection Control Meets Work Health and Safety – Learnings From Victoria during COVID-19

      When Infection Control Meets Work Health and Safety – Learnings From Victoria during COVID-19

      Date Recorded: 4th December 2020

      Time: Approx. 1.5hrs

      This webinar aims to understand and learn from the experiences of working in a COVID-positive clinical environment, in particular focusing on the impacts of the Victorian experience of COVID-19 and focus on the things done, the learnings, and the unresolved issues within the WHS space. Come join us for presentations and a panel discussion from our expert group!

      Prof Bruce Thompson (Chair) – TSANZ President

      Dr Nick Coatsworth – Federal Deputy CMO
      Dr Nick Coatsworth is one of Australia’s Deputy Chief Medical Officers. He is also the Executive Director of the Medical Services Group at Canberra Health Services. Nick held a key national role in the Australian response to COVID-19. Bringing together his skills as an infectious disease physician, a respiratory physician, a practitioner of disaster and humanitarian medicine, and high-level experience in health administration, Nick’s contribution provided a voice for frontline hospital staff in the national response to the pandemic. He became one of the most recognised medical spokespeople during the pandemic, engaging the Australian community through a variety of media platforms.

      A/Prof Lou Irving – The Royal Melbourne Hospital
      Lou Irving is Director of Respiratory and Sleep Medicine at Royal Melbourne Hospital and Director of the Lung Tumour Stream at Peter MacCallum Cancer Centre. He has been involved in clinical research over many years and has published over 230 articles.

      Ms Brigitte Borg – The Alfred
      Brigitte Borg is an accredited clinical physiologist (respiratory) with 27 years’ experience. Brigitte works at The Alfred, Melbourne as Head, Physiology Service, Respiratory Medicine. Brigitte’s areas of interest in the field of respiratory medicine include lung function interpretation (for which she co-authored a book in 2014), laboratory accreditation, quality spirometry in primary care, and oxygen therapy.

      Dr Forbes McGain – Western Health, University of Sydney and University of Melbourne
      Forbes is an anaesthetist and intensive care physician at Western Health, Melbourne, Australia, and an Associate Professor (Medicine) at the University of Sydney, and the University of Melbourne.

      He enjoys being involved in research, teaching and education at the hospital, university and beyond. In 2020, during the COVID-19 pandemic, Forbes and mechanical engineers at the University of Melbourne collaboratively produced a personal isolation hood to reduce SARS-CoV-2 transmission to healthcare workers. Forbes also remains passionate about making seemingly small environmental sustainability changes to how we practice medicine that become magnified through every nations’ hospitals.

      Ms Ceri Banks – Peninsula Health
      Ceri Banks is a Clinical Research Nurse Consultant at Peninsula Health in Melbourne. She is the coordinator of respiratory clinical trials and a Severe Asthma Clinic, managing patients undergoing bronchial thermoplasty and monoclonal therapy. She is a presenter for the National Asthma Council and co-convenor of the TSANZ Respiratory Nurses Group.

      Registration:

      To register your interest in the on-demand recording, please register below. You will then be sent an e-mail, allowing you to obtain the recording links through Vimeo.

      Category Fee (excl. GST)
      TSANZ Members Free
      Non-members $20.00

      Require assistance?

      Please contact the TSANZ Office on +61 2 9222 6200 or e-mail tsanzeducation@thoracic.org.au

      VOLUME 7.06 – JULY 2022

      VOLUME 5.06 – SEPTEMBER 2020

      Research Roundup:

      September 2020

      Welcome Message

      Welcome to another edition of our TSANZ Research Roundup. We hope that you remain well during this difficult time, and our thoughts are especially with our Victorian members who are on the front-line treating patients with COVID or facing unprecedented restrictions.

      Plans for our exciting first virtual ASM in 2021 are well underway, with abstract submissions opened on 21 September 2020 and registrations opening on 22 October 2020. Please visit our TSANZSRS2021 website for more details about abstracts, and pay close attention to the closing date of 6 November 2020. Abstracts submitted to the 2020 Annual Scientific Meeting are eligible to be resubmitted for the 2021 Annual Scientific Meeting, and all resubmitted abstracts will undergo the same robust peer review process for allocation to oral or poster sessions.

      The TSANZ Webinar Series continue, with the Society Medal and 50th Anniversary Medalpresentations on 30 September, so don’t forget to register for these exciting events.  

      Please also note the opening of the following awards that are now accessible on the TSANZ Awards Submission Portal:

      • Past Presidents Scholarship Award: this new award will support national or international travel costs to present research for early career researchers who do not have the resources available to them via their institution or workplace. Importantly, the awardee will have the support from a TSANZ Past President who will provide invaluable feedback and professional development guidance to help them develop their research presentation skills.
      • Boehringer Ingelheim New Zealand Primary Care Grant: this award addresses the issue of access to primary care in New Zealand, particularly during restrictions like those faced during the COVID-19 pandemic.

      In addition, we are pleased to announce the new CREATE PhD Scholarship, and the opening of LFA Awards:

      Finally, please consider helping us to provide essential funding for our world class respiratory researchers and for our TSANZ awards. You can leave a tax deductible donation of your choice in our areas of need, whether it be a donation to our Benevolent Fund or to support research, establishing a named award or leaving TSANZ a gift in your will. Details can be found below.

      Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

      Enjoy the September edition of your Research Roundup.

      Prof Sandra Hodge

      Chair, Research Sub-Committee

      Call for Abstracts

      Abstracts for TSANZSRS21 are now open. Abstracts submitted to the 2020 Annual Scientific Meeting are eligible to resubmit for the 2021 Annual Scientific Meeting. Please note, all resubmitted abstracts will undergo the same robust peer review process for allocation to oral or poster sessions.

      Please submit your abstract by 6 November and join us for our first ever virtual ASM in 2021!

       

      New Award: CREATE Hope Research Fund PhD Scholarships in Pulmonary Fibrosis

      The CREATE PhD Scholarships in Pulmonary Fibrosis will support research into pulmonary fibrosis in Australia

      Relevant domains of research inquiry include any form of clinical, population, laboratory, genetic or tissue based research. 

      Students who are wishing to undertake a PhD, or are currently enrolled in a PhD in Pulmonary Fibrosis Research, are invited to submit an application. The student must be a resident in Australia throughout the period of the research program.

      The Centre of Research Excellence in Pulmonary Fibrosis (the CRE-PF)  will allocate a total of two grants, each of $28,000, for the PhD Scholarships. These scholarships will either fund a stipend for one year for a full time student or may be extended over a second year, should the student be able to secure matching funds to permit extension of the period via their University or Research Institute. Extension of the funding in order to extend the value of the research investment by the Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) and Lung Foundation Australia by securing matching funding from the host institution is encouraged and will be regarded favourably.

      These funds are to be used for the student stipend. Direct, indirect research costs and/or infrastructure costs do not form part of this grant and will not be covered by this funding.

      Click here for more info!

      Open Awards

      Thoracic Society Awards

      TSANZ Past Presidents Scholarship Award – closing 04 October 2020

      Boehringer Ingelheim New Zealand Primary Care Grant – closing 04 October 2020

      TSANZ ASM 2021 abstract-linked Awards – closing 6 November 2020

       Lung Foundation Awards

      Lizotte Family Idiopathic Pulmonary Fibrosis Research Grant – closing 13 October 2020

      Ludwig Engel Grant-in-Aid for Physiological Respiratory Research – closing 13 October 2020

      Ivan Cash Grant-in-Aid For Idiopathic Pulmonary Fibrosis Research – closing 13 October 2020

      Cochrane Airways Australia Scholarship – closing 13 October 2020

      Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF)

      CREATE Hope Research Fund PhD Scholarships in Pulmonary Fibrosis – closing 31 October 2020

      How to participate

      Follow the links above to access each award application form and download the information sheet.

      Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

      Respirology – Special Issue and Editor’s Choice
       

      Respirology Issue 25.9 September 2020

       

      Special Issue: Interventional Pulmonology Pearls

       

      Cover caption: A collection of images from the Invited review series International Pumlonology Pearls.

      Illustrations credit (A to F clockwise from top left) : A and B: Pyng Lee (personal communication), C and D: Fielding and Oki p.914, E: Guibert et al. p.953, F: Shah and Slebos p.972.

      DOI: 10.1111/resp.13598

       

      Respirology Issue 25.10 October 2020

       

      Acute effects of e-cigarette vaping on pulmonary function and airway inflammation in healthy individuals and in patients with asthma

      Serafeim-Chrysovalantis Kotoulas, Athanasia Pataka, Kallipoi Domvri, Dionisios Sypratos, Paraskevi Katsaounou, Konstantinos Porpodis, Evangelia Fouka, Aikaterini Markopoulou, Katalin Passa-Fekte, Ioanna Grigoriou, Theodoros Kontakiotis, Paraskevi Argyropoulou and Despoina Papakosta

       

      Cover caption: Asthmatic and healthy smokers underwent pulmonary function tests to assess acute effects of e-cigarettes

      DOI: 10.1111/resp.13806

       

      Peer Connect Service for people with pulmonary fibrosis in Australia: Participants’ experiences and process evaluation

      Gabriella Tikellis, Joanna Y.T. Lee, Tamera J. Corte, Jamie Maloney, Michael Bartlett, Tonia Crawford, Ian N. Glaspole, Nicole Goh, Kelcie Herrmann, Alison J. Hey-Cunningham, Greg Keir, Yet H. Khor, John Price, Debra G. Sandford, Lissa Spencer, Alan Teoh, Jennifer Walsh, Susanne Webster and Anne E. Holland

       

      Cover caption:  Bill, diagnosed with IPF in 2015, is a primary peer within the Pulmonary Fibrosis Peer Connect service. (Photograph credit: Lung Foundation Australia)

      DOI: 10.1111/resp.13807

      Invitations and surveys

      BREATHE Study

      Do you have asthma, emphysema, chronic bronchitis or bronchiectasis?

      Do you live in an area affected by bushfires or bushfire smoke?

      If yes to both, you may be eligible for the BREATHE study.

      We are studying facemasks for prevention of smoke exposure

      Find out more: https://kirby.unsw.edu.au/breathe

      Please register your interest: https://www.surveymonkey.com/r/C96DXJN

      Contact us: e.kpozehouen@unsw.edu.au

      Ethics Approval: HC200477

      INVITATION TO PARTICIPATE IN AN ERS STUDY AIMING TO IMPROVE THE QUALITY OF CLINICAL TRIALS EVALUATING THE MANAGEMENT OF COPD EXACERBATIONS

      Dear colleagues,

      Clinical trials evaluating the management of chronic obstructive pulmonary disease (COPD) exacerbations evaluate heterogeneous outcomes (endpoints), often omitting those that are clinically important and relevant to patients. This limits their usability and comparability.

      To remedy this issue, the European Respiratory Society (ERS) set-up a Task Force aiming to develop a core outcome set (COS). A COS is a consensus-based minimum set of clinically important outcomes that should be evaluated in all future clinical trials on the management of COPD exacerbations.

      We have identified around 50 outcomes of COPD exacerbations and we need your help to prioritize a small number of the most important outcomes, to be included in the core outcome set and to be evaluated in all future clinical trials on the management of COPD exacerbations. To help us prioritize the outcomes, we will be grateful if you could complete a survey that has two stages, 4-8 weeks apart. Each survey takes about 20 minutes to complete.

      In the first survey, you will be asked to rate the importance of 50 outcomes between 1-9:

      • 1-3: Outcomes of limited importance.
      • 4-6: Outcomes that are important but not critical.
      • 7-9: Critical outcomes.

      We welcome responses from health professionals, researchers, patients with COPD and any other stakeholders with interest in COPD exacerbations.

      In the second survey, you will see a graph summarizing the responses of all participants in the first survey and you will be asked to reconsider your ratings, taking into consideration the views of the other responders. While the aim of this survey will be to reach consensus, you will not have to change your ratings if you do not want to.

      Your opinion in both surveys is extremely important in developing the core outcome set.

      It is crucial that you complete both surveys and we would be very grateful if you can do this.

      Please, take the survey in one of the following languages:

      English: https://delphimanager.liv.ac.uk/COPD/
      Portuguese: https://delphimanager.liv.ac.uk/COPD-PO/
      German: https://delphimanager.liv.ac.uk/COPD-GE/
      Hungarian:  https://delphimanager.liv.ac.uk/COPD-HU/
      Mandarin: https://delphimanager.liv.ac.uk/COPD-CN/
      Spanish: https://delphimanager.liv.ac.uk/COPD-ES/
      Russian: https://delphimanager.liv.ac.uk/COPD-RU/
      Greek: https://delphimanager.liv.ac.uk/COPD-GR/
      Danish: https://delphimanager.liv.ac.uk/COPD-DK/
      Italian: https://delphimanager.liv.ac.uk/COPD-IT/

      We appreciate this is a difficult time for patients and professionals in the respiratory community. While all efforts should rightly be focused on caring for those affected by the novel coronavirus and COVID-19, we believe that research to improve care and outcomes for respiratory patients is needed now more than ever. We are sensitive to the enormous pressures faced by patients and professionals in our community and will review the timelines for this survey and subsequent work in response to the ongoing global pandemic.

      Thank you very much in advance,
      Kind regards,
      Associate Prof. Jens-Ulrik Jensen,
      Dr. Alexander Mathioudakis,
      Prof. Jørgen Vestbo,
      On behalf of the study team.

       

      GLOBAL CURRENT PRACTICES OF MECHANICAL VENTILATION MANAGEMENT IN COVID-19 PATIENTS

      Dear Colleague, 

      You are invited to partake in the current study, “Global Current Practices of Mechanical Ventilation Management in COVID-19 Patients.” The goal of this study is to explore the current practices of mechanical ventilation support in adult COVID-19 patients worldwide. 

      We are carrying out this online survey for frontline clinicians involved in the care of patients with COVID-19, with the aim to examine which ventilation techniques healthcare providers’ used to manage adult COVID-19 patients. It would be helpful if you could complete this survey, the estimated time is 5-10 minutes. While there is limited information available on ventilatory support practices in COVID-19 patients, this international survey will provide further insights into current strengths and limitations of global practices.

      Rest assured that your answers will be kept confidential, and no information will be used to identify you or your response. This research project was approved by the Institutional Review Board (IRB), AFHER-IRB-2020-012.

      If you have any concern or question regarding this study, please do not hesitate to contact me at Jaber.alqahtani.18@ucl.ac.uk.

      THANK YOU!
      Jaber Alqahtani
      On behalf of the whole international team

       

      INVITATION TO PARTICIPATE IN A STUDY ON SELF MANAGEMENT FOR PULMONARY FIBROSIS: WHAT DOES IT MEAN AND HOW MIGHT IT HELP?

      Dear Members of the Thoracic Society of Australia and New Zealand, 

      Alfred Health and the Centre of Research Excellence in Pulmonary Fibrosis are inviting health professionals involved with pulmonary fibrosis (PF) to take part in a study on self-management for pulmonary fibrosis: what does it mean and how might it help? 

      Participation is voluntary and involves you sharing your views, opinions and experiences on the patients’ management of PF through a confidential telephone interview of about 30 minutes in duration

      Your perspective is important to help us identify and develop resources that will provide patients with the knowledge and tools to manage their own wellbeing. In turn, this will help health professionals to be better equipped to provide support to people with PF and their families. 

      The study has been approved by the Alfred Health Human Ethics Committee (Project number: 144/20). 

      If you are interested in participating or would like further information on this study, please contact: 

      Professor Anne Holland (Chief Investigator) 
      Professor of Physiotherapy, 
      Monash University and Alfred Health 
      Email: Anne.Holland@monash.edu 
      Telephone: (03) 9903 0214 

      Ms Joanna Lee (PhD candidate)
      Monash University and Alfred Health
      Email: joanna.lee2@monash.edu
      Mobile: 0431 689 361

      Thank you for your time and consideration of our study. 

      ASCOT trial

      ASCOT is a clinical trial that will generate clinical evidence about treatment for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

      The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand and Asia. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

      Potential Treatments for COVID-19

      There are currently no specific therapies for COVID-19. The two main strategies are to limit the virus replicating (antiviral therapies) or to modulate the immune response (in some severe cases, there is a damaging over exuberant immune response).

      ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

      ASCOT Trial Intervention

      Initially, an open label trial of two existing treatments in a 2×2 factorial design with usual care arm will be conducted.

      1. Lopinavir/ritonavir (kaletra), a combination medicine that is used to treat human immunodeficiency virus-1 (HIV-1) infection
      1. Hydroxychloroquine, a medicine used to treat rheumatoid arthritis and other inflammatory conditions and to prevent and treat malaria.

      Protocol documents and further details are available at www.ascot-trial.edu.au

       

      Can you help TSANZ make a difference?
       

      Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

      1. Making a donation to our Benevolent Fund

      The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
      CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      2. Making a donation to support research

      With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
      Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      3. Establishing a named award

      For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

      4. Leave TSANZ a gift in your will

      If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
      If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

      5. TSANZ New Zealand Branch Incorporated 

      New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
      CLICK HERE to make a donation.

      Thank you for your continued support of TSANZ

      .

       

      WHY JOIN US?

      Become part of a network of professionals working in respiratory and lung health clinical care and treatment, research, health promotion and advocacy.

      By browsing our website you agree to our use of cookies outlined in our revised Privacy Policy and Terms & Conditions.

      X